Mb76的个人主页 - 老虎社区

Mb76

暂无个人介绍

IP属地：未知

218关注

12粉丝

0主题

0勋章

2021-11-21

K

Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>

2021-08-06

K

抱歉，原内容已删除

2021-11-19

K

Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>

2021-11-18

K

抱歉，原内容已删除

2021-10-21

K

抱歉，原内容已删除

2021-10-07

K

Here are 10 'high conviction' stocks of companies with strong pricing power and at least 20% upside potential to UBS targets<blockquote>以下是10只“高度确信”的公司股票，它们具有强大的定价能力，比瑞银目标至少有20%的上涨潜力</blockquote>

2021-09-10

K

抱歉，原内容已删除

2021-11-13

K

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>

2021-10-29

K

抱歉，原内容已删除

2021-10-27

K

Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087701475296490","uuid":"4087701475296490","gmtCreate":1624606819880,"gmtModify":1624606819880,"name":"Mb76","pinyin":"mb76","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":218,"tweetSize":96,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":602986550,"gmtCreate":1638957383798,"gmtModify":1638957384004,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602986550","repostId":"1179611425","repostType":4,"isVote":1,"tweetType":1,"viewCount":2716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603025507,"gmtCreate":1638342965288,"gmtModify":1638342965377,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603025507","repostId":"1136781080","repostType":4,"repost":{"id":"1136781080","kind":"news","pubTimestamp":1638341251,"share":"https://www.laohu8.com/m/news/1136781080?lang=zh_CN&edition=full","pubTime":"2021-12-01 14:47","market":"hk","language":"en","title":"What Powell’s Hawkish Transition Could Mean for Asian Markets<blockquote>鲍威尔的鹰派转型对亚洲市场意味着什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1136781080","media":"Bloomberg","summary":"Strategists bearish on implications for Asia equities and FX\nHigher U.S. rates could trigger capital","content":"<p><ul>  <li>Strategists bearish on implications for Asia equities and FX</li>  <li>Higher U.S. rates could trigger capital flows out of region</li> </ul> Jerome Powell sent a stir through global markets Tuesday, paving the way for quicker-than-expected U.S. hikes, which would ripple through rate-sensitive Asian assets.</p><p><blockquote><ul><li>策略师对亚洲股市和外汇的影响持悲观态度</li><li>美国利率上升可能引发资本流出该地区</li></ul>杰罗姆·鲍威尔周二在全球市场引起轰动，为美国超预期加息铺平了道路，这将波及对利率敏感的亚洲资产。</blockquote></p><p> The Federal Reserve Chair&nbsp;told&nbsp;Congress that policymakers will discuss whether to wrap up bond purchases a few months earlier and retired the word “transitory” from his commentary on inflation. Higher U.S. rates would have a significant impact on Asian assets if capital flows to America. A stronger greenback has implications for Asia’s export-heavy companies and economies and the dollar-denominated debt of the region’s sovereign and corporate borrowers.</p><p><blockquote>美联储主席告诉国会，政策制定者将在几个月前讨论是否结束债券购买，并从他对通胀的评论中删除了“暂时”一词。如果资本流向美国，美国利率上升将对亚洲资产产生重大影响。美元走强对亚洲以出口为主的企业和经济体，以及该地区主权和企业借款人以美元计价的债务都有影响。</blockquote></p><p> Still, Asia stocks and currencies are rallying Wednesday with some strategists saying Powell’s comments about a faster taper weren’t unexpected. His nod toward the uncertainty caused by the omicron variant has also blunted the hawkish tone, according to Tomo Kinoshita, global market strategist at Invesco Asset Management.</p><p><blockquote>尽管如此，亚洲股市和货币周三仍在上涨，一些策略师表示，鲍威尔关于加快缩减规模的言论并不出人意料。景顺资产管理公司全球市场策略师Tomo Kinoshita表示，他对奥密克戎变体造成的不确定性的认可也削弱了鹰派基调。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fe5fb6c8c29a959328a059ba71b72f5f\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Here are the thoughts of Asia watchers on what Powell’s shift means for the region’s markets:</p><p><blockquote>以下是亚洲观察人士对鲍威尔的转变对该地区市场意味着什么的看法：</blockquote></p><p> <b>Deferring to the Dollar</b></p><p><blockquote><b>遵从美元</b></blockquote></p><p> “Prospects of quicker taper and higher U.S. rates will stress test the allure of higher returns in EM Asia and as a consequence the ‘stickiness’ of funds parked in this part of the world,” said Vishnu Varathan, head of economics and strategy at Mizuho Bank Ltd in Singapore.</p><p><blockquote>瑞穗银行经济与战略主管Vishnu Varathan表示：“更快缩减规模和美国利率上升的前景将对亚洲新兴市场更高回报的吸引力进行压力测试，从而影响存放在世界这一地区的资金的‘粘性’。”银行有限公司位于新加坡。</blockquote></p><p> “We have long maintained that the outcome will be ‘KokomoFed,’ that gets there fast and then takes it slow after,” he said, referring to a Beach Boys song. “And this in turn will prompt a ‘Kokomo dollar,’ whereby the bias is for the dollar to be skewed to strength.”</p><p><blockquote>“我们长期以来一直坚持认为，结果将是‘KokomoFed’，快速到达那里，然后缓慢，”他说，指的是沙滩男孩的一首歌曲。“这反过来将催生‘科科莫美元’，即美元偏向强势。”</blockquote></p><p> <b>Bad for High Beta</b></p><p><blockquote><b>不利于高贝塔</b></blockquote></p><p> “The threat of faster tapering is bad news for high-beta markets such as EM,” said Sue Trinh, managing director for global macro strategy at Manulife Investment Management in Hong Kong.</p><p><blockquote>宏利投资管理公司驻香港全球宏观策略董事总经理Sue Trinh表示：“对于新兴市场等高贝塔市场来说，更快缩减规模的威胁是个坏消息。”</blockquote></p><p> “Yet we have been of the view that Asia is well-placed within EM to withstand any potential monetary volatility -- inflation in Asia more contained and Asia is less reliant on foreign capital than other EM,” she said. “The not-so-good news for Asia is that the region is far too reliant on foreign demand to absorb its exports.”</p><p><blockquote>她说：“然而，我们一直认为，亚洲在新兴市场中处于有利地位，能够抵御任何潜在的货币波动——与其他新兴市场相比，亚洲的通胀得到了更好的控制，而且亚洲对外国资本的依赖程度较低。”“对亚洲来说，不太好的消息是该地区过于依赖外国需求来吸收其出口。”</blockquote></p><p> <b>Risk Asset Pressure</b></p><p><blockquote><b>风险资产压力</b></blockquote></p><p> “Expect more pressure on risk assets in general, including Asian equities,” said Alvin T. Tan, head of Asia FX strategy at RBC Capital Markets in Hong Kong.</p><p><blockquote>加拿大皇家银行资本市场驻香港亚洲外汇策略主管Alvin T.Tan表示：“预计包括亚洲股市在内的整体风险资产将面临更大压力。”</blockquote></p><p> “However, Asian FX have held up really well in this latest risk-off bout, and that was because the whole market was furiously loading up on U.S. dollars right into the omicron news,” he added. “So it is U.S. dollars that are being unwound this time. In that way it has been an unusual ‘risk-off’ experience, though JPY has behaved more conventionally.”</p><p><blockquote>“然而，亚洲外汇在最近的这场避险回合中表现非常好，这是因为整个市场在奥密克戎新闻发布后疯狂买入美元，”他补充道。“因此，这一次美元被解除了赎回权。从这个角度来看，这是一次不寻常的‘避险’经历，尽管日元的表现更加传统。”</blockquote></p><p> <b>Focus on Renminbi</b></p><p><blockquote><b>关注人民币</b></blockquote></p><p> “We expect the Thai baht to be most at risk, especially since it has an additional negative that the re-emergence of Covid-19 concerns will potentially further set back the return of tourism,” said Terence Wu, a foreign-exchange strategist at Oversea-Chinese Banking Corp. in Singapore.</p><p><blockquote>外汇策略师Terence Wu表示：“我们预计泰铢面临的风险最大，特别是因为它还有一个额外的负面影响，即Covid-19担忧的重新出现可能会进一步阻碍旅游业的回归。”新加坡华侨银行。</blockquote></p><p> “More importantly, we will be watching closely developments in the renminbi. The RMB has been strong on a basket basis, and that has sheltered the Asian currencies. Should the RMB start to show signs of weakness, expect the flow-through of dollar strength to the EM Asian currencies to be stronger.”</p><p><blockquote>“更重要的是，我们将密切关注人民币的发展。人民币在一篮子货币基础上一直走强，这对亚洲货币起到了保护作用。如果人民币开始出现疲软迹象，预计美元走强将会对亚洲新兴市场货币产生更强影响。”</blockquote></p><p> <b>China Chance</b></p><p><blockquote><b>中国机会</b></blockquote></p><p> “Extreme dollar strength because of higher U.S. interest rates is a headwind for Asia and EM equities, but China and large Asean markets such as Indonesia could still outperform western markets in 2022 because of reversion to mean,” said Michael Rainer Preiss, portfolio strategist at Golden Equator Wealth. “China already had a big correction and the valuation argument for China equities is getting stronger.”</p><p><blockquote>投资组合策略师Michael Rainer Preiss表示：“由于美国利率上升，美元极度走强对亚洲和新兴市场股市来说是一个阻力，但由于回归均值，中国和印度尼西亚等大型东盟市场在2022年仍可能跑赢西方市场。”在金赤道财富。“中国已经经历了大幅调整，中国股市的估值论据越来越强。”</blockquote></p><p> <b>Mixed Asian FX</b></p><p><blockquote><b>混合亚洲外汇</b></blockquote></p><p> “While Powell’s comments suggest the Fed could bring forward their rate hike to as soon as the middle of 2022, the dollar failed to rally on the back of this.,” said Khoon Goh, head of Asia research at Australia &amp; New Zealand Banking Group in Singapore. “This is likely because the Fed Chair’s statement is only matching market expectations.”</p><p><blockquote>澳大利亚和新西兰银行集团亚洲研究主管Khoon Goh表示：“虽然鲍威尔的言论表明美联储最早可能将加息提前至2022年年中，但美元未能在此基础上反弹。”在新加坡。“这很可能是因为美联储主席的声明只是符合市场预期。”</blockquote></p><p> “The impact on Asian FX will likely be mixed. With export growth still strong in the region, as shown by today’s stronger than expected Korean numbers, currencies of export driven economies like KRW, CNH and SGD will fare well. Prospects for higher U.S. yields could weigh slightly on IDR due to reduced foreign bond inflows. THB will be more influenced by how the Omicron variant may affect Thailand’s tourism reopening.”</p><p><blockquote>“对亚洲外汇的影响可能是喜忧参半。由于该地区的出口增长仍然强劲，正如今天强于预期的韩国数据所显示的那样，韩元、CNH和新加坡元等出口驱动型经济体的货币将表现良好。由于外国债券流入减少，美国收益率上升的前景可能会略微打压印度卢比。泰铢将更多地受到奥密克戎变种如何影响泰国旅游业重新开放的影响。”</blockquote></p><p> <b>Thin Spreads</b></p><p><blockquote><b>稀薄价差</b></blockquote></p><p></p><p> The spread cushion on Asian dollar bonds from rising Treasury yields is “thin at best” with valuations near multi-year tights, with the exception of China’s property issuers, according to Ek Pon Tay, BNP Paribas Asset Management’s senior portfolio manager in Singapore.</p><p><blockquote>法国巴黎资产管理公司驻新加坡高级投资组合经理Ek Pon Tay表示，美国国债收益率上升对亚洲美元债券的利差缓冲“充其量很薄”，估值接近多年低点，但中国房地产发行人除外。</blockquote></p><p> Tay recommends investors overweight investment-grade rated China property credits as these issuers are likely to survive in the event of a prolonged sector downturn and valuations offer ample spread cushion versus others.</p><p><blockquote>Tay向投资者推荐跑赢大盘投资级评级的中华地产信贷，因为这些发行人可能会在行业长期低迷的情况下生存下来，而且估值与其他发行人相比提供了充足的利差缓冲。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Powell’s Hawkish Transition Could Mean for Asian Markets<blockquote>鲍威尔的鹰派转型对亚洲市场意味着什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Powell’s Hawkish Transition Could Mean for Asian Markets<blockquote>鲍威尔的鹰派转型对亚洲市场意味着什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-01 14:47</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul>  <li>Strategists bearish on implications for Asia equities and FX</li>  <li>Higher U.S. rates could trigger capital flows out of region</li> </ul> Jerome Powell sent a stir through global markets Tuesday, paving the way for quicker-than-expected U.S. hikes, which would ripple through rate-sensitive Asian assets.</p><p><blockquote><ul><li>策略师对亚洲股市和外汇的影响持悲观态度</li><li>美国利率上升可能引发资本流出该地区</li></ul>杰罗姆·鲍威尔周二在全球市场引起轰动，为美国超预期加息铺平了道路，这将波及对利率敏感的亚洲资产。</blockquote></p><p> The Federal Reserve Chair&nbsp;told&nbsp;Congress that policymakers will discuss whether to wrap up bond purchases a few months earlier and retired the word “transitory” from his commentary on inflation. Higher U.S. rates would have a significant impact on Asian assets if capital flows to America. A stronger greenback has implications for Asia’s export-heavy companies and economies and the dollar-denominated debt of the region’s sovereign and corporate borrowers.</p><p><blockquote>美联储主席告诉国会，政策制定者将在几个月前讨论是否结束债券购买，并从他对通胀的评论中删除了“暂时”一词。如果资本流向美国，美国利率上升将对亚洲资产产生重大影响。美元走强对亚洲以出口为主的企业和经济体，以及该地区主权和企业借款人以美元计价的债务都有影响。</blockquote></p><p> Still, Asia stocks and currencies are rallying Wednesday with some strategists saying Powell’s comments about a faster taper weren’t unexpected. His nod toward the uncertainty caused by the omicron variant has also blunted the hawkish tone, according to Tomo Kinoshita, global market strategist at Invesco Asset Management.</p><p><blockquote>尽管如此，亚洲股市和货币周三仍在上涨，一些策略师表示，鲍威尔关于加快缩减规模的言论并不出人意料。景顺资产管理公司全球市场策略师Tomo Kinoshita表示，他对奥密克戎变体造成的不确定性的认可也削弱了鹰派基调。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fe5fb6c8c29a959328a059ba71b72f5f\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Here are the thoughts of Asia watchers on what Powell’s shift means for the region’s markets:</p><p><blockquote>以下是亚洲观察人士对鲍威尔的转变对该地区市场意味着什么的看法：</blockquote></p><p> <b>Deferring to the Dollar</b></p><p><blockquote><b>遵从美元</b></blockquote></p><p> “Prospects of quicker taper and higher U.S. rates will stress test the allure of higher returns in EM Asia and as a consequence the ‘stickiness’ of funds parked in this part of the world,” said Vishnu Varathan, head of economics and strategy at Mizuho Bank Ltd in Singapore.</p><p><blockquote>瑞穗银行经济与战略主管Vishnu Varathan表示：“更快缩减规模和美国利率上升的前景将对亚洲新兴市场更高回报的吸引力进行压力测试，从而影响存放在世界这一地区的资金的‘粘性’。”银行有限公司位于新加坡。</blockquote></p><p> “We have long maintained that the outcome will be ‘KokomoFed,’ that gets there fast and then takes it slow after,” he said, referring to a Beach Boys song. “And this in turn will prompt a ‘Kokomo dollar,’ whereby the bias is for the dollar to be skewed to strength.”</p><p><blockquote>“我们长期以来一直坚持认为，结果将是‘KokomoFed’，快速到达那里，然后缓慢，”他说，指的是沙滩男孩的一首歌曲。“这反过来将催生‘科科莫美元’，即美元偏向强势。”</blockquote></p><p> <b>Bad for High Beta</b></p><p><blockquote><b>不利于高贝塔</b></blockquote></p><p> “The threat of faster tapering is bad news for high-beta markets such as EM,” said Sue Trinh, managing director for global macro strategy at Manulife Investment Management in Hong Kong.</p><p><blockquote>宏利投资管理公司驻香港全球宏观策略董事总经理Sue Trinh表示：“对于新兴市场等高贝塔市场来说，更快缩减规模的威胁是个坏消息。”</blockquote></p><p> “Yet we have been of the view that Asia is well-placed within EM to withstand any potential monetary volatility -- inflation in Asia more contained and Asia is less reliant on foreign capital than other EM,” she said. “The not-so-good news for Asia is that the region is far too reliant on foreign demand to absorb its exports.”</p><p><blockquote>她说：“然而，我们一直认为，亚洲在新兴市场中处于有利地位，能够抵御任何潜在的货币波动——与其他新兴市场相比，亚洲的通胀得到了更好的控制，而且亚洲对外国资本的依赖程度较低。”“对亚洲来说，不太好的消息是该地区过于依赖外国需求来吸收其出口。”</blockquote></p><p> <b>Risk Asset Pressure</b></p><p><blockquote><b>风险资产压力</b></blockquote></p><p> “Expect more pressure on risk assets in general, including Asian equities,” said Alvin T. Tan, head of Asia FX strategy at RBC Capital Markets in Hong Kong.</p><p><blockquote>加拿大皇家银行资本市场驻香港亚洲外汇策略主管Alvin T.Tan表示：“预计包括亚洲股市在内的整体风险资产将面临更大压力。”</blockquote></p><p> “However, Asian FX have held up really well in this latest risk-off bout, and that was because the whole market was furiously loading up on U.S. dollars right into the omicron news,” he added. “So it is U.S. dollars that are being unwound this time. In that way it has been an unusual ‘risk-off’ experience, though JPY has behaved more conventionally.”</p><p><blockquote>“然而，亚洲外汇在最近的这场避险回合中表现非常好，这是因为整个市场在奥密克戎新闻发布后疯狂买入美元，”他补充道。“因此，这一次美元被解除了赎回权。从这个角度来看，这是一次不寻常的‘避险’经历，尽管日元的表现更加传统。”</blockquote></p><p> <b>Focus on Renminbi</b></p><p><blockquote><b>关注人民币</b></blockquote></p><p> “We expect the Thai baht to be most at risk, especially since it has an additional negative that the re-emergence of Covid-19 concerns will potentially further set back the return of tourism,” said Terence Wu, a foreign-exchange strategist at Oversea-Chinese Banking Corp. in Singapore.</p><p><blockquote>外汇策略师Terence Wu表示：“我们预计泰铢面临的风险最大，特别是因为它还有一个额外的负面影响，即Covid-19担忧的重新出现可能会进一步阻碍旅游业的回归。”新加坡华侨银行。</blockquote></p><p> “More importantly, we will be watching closely developments in the renminbi. The RMB has been strong on a basket basis, and that has sheltered the Asian currencies. Should the RMB start to show signs of weakness, expect the flow-through of dollar strength to the EM Asian currencies to be stronger.”</p><p><blockquote>“更重要的是，我们将密切关注人民币的发展。人民币在一篮子货币基础上一直走强，这对亚洲货币起到了保护作用。如果人民币开始出现疲软迹象，预计美元走强将会对亚洲新兴市场货币产生更强影响。”</blockquote></p><p> <b>China Chance</b></p><p><blockquote><b>中国机会</b></blockquote></p><p> “Extreme dollar strength because of higher U.S. interest rates is a headwind for Asia and EM equities, but China and large Asean markets such as Indonesia could still outperform western markets in 2022 because of reversion to mean,” said Michael Rainer Preiss, portfolio strategist at Golden Equator Wealth. “China already had a big correction and the valuation argument for China equities is getting stronger.”</p><p><blockquote>投资组合策略师Michael Rainer Preiss表示：“由于美国利率上升，美元极度走强对亚洲和新兴市场股市来说是一个阻力，但由于回归均值，中国和印度尼西亚等大型东盟市场在2022年仍可能跑赢西方市场。”在金赤道财富。“中国已经经历了大幅调整，中国股市的估值论据越来越强。”</blockquote></p><p> <b>Mixed Asian FX</b></p><p><blockquote><b>混合亚洲外汇</b></blockquote></p><p> “While Powell’s comments suggest the Fed could bring forward their rate hike to as soon as the middle of 2022, the dollar failed to rally on the back of this.,” said Khoon Goh, head of Asia research at Australia &amp; New Zealand Banking Group in Singapore. “This is likely because the Fed Chair’s statement is only matching market expectations.”</p><p><blockquote>澳大利亚和新西兰银行集团亚洲研究主管Khoon Goh表示：“虽然鲍威尔的言论表明美联储最早可能将加息提前至2022年年中，但美元未能在此基础上反弹。”在新加坡。“这很可能是因为美联储主席的声明只是符合市场预期。”</blockquote></p><p> “The impact on Asian FX will likely be mixed. With export growth still strong in the region, as shown by today’s stronger than expected Korean numbers, currencies of export driven economies like KRW, CNH and SGD will fare well. Prospects for higher U.S. yields could weigh slightly on IDR due to reduced foreign bond inflows. THB will be more influenced by how the Omicron variant may affect Thailand’s tourism reopening.”</p><p><blockquote>“对亚洲外汇的影响可能是喜忧参半。由于该地区的出口增长仍然强劲，正如今天强于预期的韩国数据所显示的那样，韩元、CNH和新加坡元等出口驱动型经济体的货币将表现良好。由于外国债券流入减少，美国收益率上升的前景可能会略微打压印度卢比。泰铢将更多地受到奥密克戎变种如何影响泰国旅游业重新开放的影响。”</blockquote></p><p> <b>Thin Spreads</b></p><p><blockquote><b>稀薄价差</b></blockquote></p><p></p><p> The spread cushion on Asian dollar bonds from rising Treasury yields is “thin at best” with valuations near multi-year tights, with the exception of China’s property issuers, according to Ek Pon Tay, BNP Paribas Asset Management’s senior portfolio manager in Singapore.</p><p><blockquote>法国巴黎资产管理公司驻新加坡高级投资组合经理Ek Pon Tay表示，美国国债收益率上升对亚洲美元债券的利差缓冲“充其量很薄”，估值接近多年低点，但中国房地产发行人除外。</blockquote></p><p> Tay recommends investors overweight investment-grade rated China property credits as these issuers are likely to survive in the event of a prolonged sector downturn and valuations offer ample spread cushion versus others.</p><p><blockquote>Tay向投资者推荐跑赢大盘投资级评级的中华地产信贷，因为这些发行人可能会在行业长期低迷的情况下生存下来，而且估值与其他发行人相比提供了充足的利差缓冲。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.bloomberg.com/news/articles/2021-12-01/what-powell-s-hawkish-transition-could-mean-for-asian-markets\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-01/what-powell-s-hawkish-transition-could-mean-for-asian-markets","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136781080","content_text":"Strategists bearish on implications for Asia equities and FX\nHigher U.S. rates could trigger capital flows out of region\n\nJerome Powell sent a stir through global markets Tuesday, paving the way for quicker-than-expected U.S. hikes, which would ripple through rate-sensitive Asian assets.\nThe Federal Reserve Chair told Congress that policymakers will discuss whether to wrap up bond purchases a few months earlier and retired the word “transitory” from his commentary on inflation. Higher U.S. rates would have a significant impact on Asian assets if capital flows to America. A stronger greenback has implications for Asia’s export-heavy companies and economies and the dollar-denominated debt of the region’s sovereign and corporate borrowers.\nStill, Asia stocks and currencies are rallying Wednesday with some strategists saying Powell’s comments about a faster taper weren’t unexpected. His nod toward the uncertainty caused by the omicron variant has also blunted the hawkish tone, according to Tomo Kinoshita, global market strategist at Invesco Asset Management.\n\nHere are the thoughts of Asia watchers on what Powell’s shift means for the region’s markets:\nDeferring to the Dollar\n“Prospects of quicker taper and higher U.S. rates will stress test the allure of higher returns in EM Asia and as a consequence the ‘stickiness’ of funds parked in this part of the world,” said Vishnu Varathan, head of economics and strategy at Mizuho Bank Ltd in Singapore.\n“We have long maintained that the outcome will be ‘KokomoFed,’ that gets there fast and then takes it slow after,” he said, referring to a Beach Boys song. “And this in turn will prompt a ‘Kokomo dollar,’ whereby the bias is for the dollar to be skewed to strength.”\nBad for High Beta\n“The threat of faster tapering is bad news for high-beta markets such as EM,” said Sue Trinh, managing director for global macro strategy at Manulife Investment Management in Hong Kong.\n“Yet we have been of the view that Asia is well-placed within EM to withstand any potential monetary volatility -- inflation in Asia more contained and Asia is less reliant on foreign capital than other EM,” she said. “The not-so-good news for Asia is that the region is far too reliant on foreign demand to absorb its exports.”\nRisk Asset Pressure\n“Expect more pressure on risk assets in general, including Asian equities,” said Alvin T. Tan, head of Asia FX strategy at RBC Capital Markets in Hong Kong.\n“However, Asian FX have held up really well in this latest risk-off bout, and that was because the whole market was furiously loading up on U.S. dollars right into the omicron news,” he added. “So it is U.S. dollars that are being unwound this time. In that way it has been an unusual ‘risk-off’ experience, though JPY has behaved more conventionally.”\nFocus on Renminbi\n“We expect the Thai baht to be most at risk, especially since it has an additional negative that the re-emergence of Covid-19 concerns will potentially further set back the return of tourism,” said Terence Wu, a foreign-exchange strategist at Oversea-Chinese Banking Corp. in Singapore.\n“More importantly, we will be watching closely developments in the renminbi. The RMB has been strong on a basket basis, and that has sheltered the Asian currencies. Should the RMB start to show signs of weakness, expect the flow-through of dollar strength to the EM Asian currencies to be stronger.”\nChina Chance\n“Extreme dollar strength because of higher U.S. interest rates is a headwind for Asia and EM equities, but China and large Asean markets such as Indonesia could still outperform western markets in 2022 because of reversion to mean,” said Michael Rainer Preiss, portfolio strategist at Golden Equator Wealth. “China already had a big correction and the valuation argument for China equities is getting stronger.”\nMixed Asian FX\n“While Powell’s comments suggest the Fed could bring forward their rate hike to as soon as the middle of 2022, the dollar failed to rally on the back of this.,” said Khoon Goh, head of Asia research at Australia & New Zealand Banking Group in Singapore. “This is likely because the Fed Chair’s statement is only matching market expectations.”\n“The impact on Asian FX will likely be mixed. With export growth still strong in the region, as shown by today’s stronger than expected Korean numbers, currencies of export driven economies like KRW, CNH and SGD will fare well. Prospects for higher U.S. yields could weigh slightly on IDR due to reduced foreign bond inflows. THB will be more influenced by how the Omicron variant may affect Thailand’s tourism reopening.”\nThin Spreads\nThe spread cushion on Asian dollar bonds from rising Treasury yields is “thin at best” with valuations near multi-year tights, with the exception of China’s property issuers, according to Ek Pon Tay, BNP Paribas Asset Management’s senior portfolio manager in Singapore.\nTay recommends investors overweight investment-grade rated China property credits as these issuers are likely to survive in the event of a prolonged sector downturn and valuations offer ample spread cushion versus others.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2606,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872811057,"gmtCreate":1637471923847,"gmtModify":1637471923971,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872811057","repostId":"1156888846","repostType":4,"repost":{"id":"1156888846","kind":"news","pubTimestamp":1637465976,"share":"https://www.laohu8.com/m/news/1156888846?lang=zh_CN&edition=full","pubTime":"2021-11-21 11:39","market":"us","language":"en","title":"Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156888846","media":"Benzinga","summary":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shel","content":"<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","RIVN":"Rivian Automotive, Inc."},"source_url":"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156888846","content_text":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether.\nWhat Happened:As Ford steps on the gas on its EV transition, the Detroit-based automaker has decided to abandon it plans to jointly develop an EV with Rivian, CEO Jim Farley said in an interview with Automotive News.\nFarley said Ford expects to produce 600,000 vehicles per year by the end of 2023.\nWhen Ford initially invested $500 million in Rivian in 2019, it envisaged developing a Ford branded EV that will come with Rivian's skateboard powertrain. In early 2020, the companies said they are shelving the plans for a Lincoln-branded EV but would go ahead with an alternative vehicle based on Rivian technology.\nThe Ford CEO suggested in the interview that the company is now increasingly confident in competing in the EV space by itself. Another handicap that forced the going-solo decision was the complexities involved in integrating the hardware and software together.\nWhy It's Important:Rivian shares debuted on Wall Street on Nov. 10 following aninitial public offeringat a bumper valuation of over $100 billion. The company's strong debut and the subsequent run up in shares have raised eyebrows over its valuation which has taken it past the market capitalization of legacy U.S. automakers, including Ford.\nRivian's product pipeline consists of RIT, an EV pickup truck, which it began delivering to customers in September. As of Oct. 30, the company produced 180 R1Ts and delivered 156 R1Ts, with the bulk of them going to the company's employees.\nThe company noted that at the end of October, it had preorders of about 55,400 R1Ts and R1Ss. It expects to fill the preorder backlog by the end of 2023.\nFord, for its part, has doubled on itsEV strategyand invested big dollars into its transition toward EVs.\n\"We respect Rivian and have had extensive exploratory discussions with them, however, both sides have agreed not to pursue any kind of joint vehicle development or platform sharing,\" Ford said in an emailed statement to media.\nRivian, meanwhile, confirmed that it is a mutual decision to focus on each of their own projects and deliveries, given Ford has scaled its own EV strategy and demand for Rivian vehicles has grown.\n\"Our relationship with Ford is an important part of our journey, and Ford remains an investor and ally on our shared path to an electrified future\" a Rivian spokesperson said.\nRivian closed Friday's session up 4.23% at $128.60, while Ford closed down 0.87% at $19.39.","news_type":1,"symbols_score_info":{"RIVN":0.9,"F":0.9}},"isVote":1,"tweetType":1,"viewCount":3666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876517849,"gmtCreate":1637331621619,"gmtModify":1637331621888,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876517849","repostId":"1156692377","repostType":4,"repost":{"id":"1156692377","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637326873,"share":"https://www.laohu8.com/m/news/1156692377?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156692377","media":"Tiger Newspress","summary":"Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors aft","content":"<p>Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.</p><p><blockquote>纳斯达克指数期货周五创下历史新高，因投资者在对总统乔·拜登1.75万亿美元支出法案的投票小幅推迟后寻求经济稳定的行业，而欧洲不断上升的COVID-19病例也削弱了市场情绪。</blockquote></p><p> S&amp;P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.</p><p><blockquote>标准普尔和道指期货下跌，跟踪银行、航空和其他经济敏感行业的损失。通胀上升和美联储紧缩政策的不确定性也使价值股的需求保持低位。</blockquote></p><p> At 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&amp;P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.</p><p><blockquote>美国东部时间上午7:55，道琼斯电子迷你指数下跌250点，即0.7%。标普500 e-mini下跌14点，即0.3%，纳斯达克100 e-mini上涨66.25点，即0.4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4d60c72fda7c9c4bcde12af36bdc2f99\" tg-width=\"414\" tg-height=\"185\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Shares of Alphabet Inc, Amazon.com&nbsp;and Microsoft Corp&nbsp;- stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.</p><p><blockquote>Alphabet公司、亚马逊公司和微软公司的股价自2020年以来基本上经受住了经济冲击，在盘前交易中上涨了0.3%至0.6%。</blockquote></p><p> Chipmaker Nvidia&nbsp;also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.</p><p><blockquote>芯片制造商英伟达(Nvidia)也提振了纳斯达克期货，在周三晚间公布强劲的季度业绩后，在大量交易中上涨1.4%。</blockquote></p><p> On the other hand, carriers Delta Air Lines, United Airlines&nbsp;and American Airlines, and cruiseliners Norwegian Cruise Line&nbsp;and Carnival Corp&nbsp;fell between 1.4% and 3%.</p><p><blockquote>另一方面，达美航空、联合航空和美国航空以及挪威邮轮和嘉年华公司的跌幅在1.4%至3%之间。</blockquote></p><p> Oil firms Exxon Mobil&nbsp;and Chevron Corp&nbsp;slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase &amp; Co&nbsp;and Bank of America&nbsp;were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.</p><p><blockquote>随着原油价格下跌，石油公司埃克森美孚和雪佛龙公司分别下跌2.7%和2.4%，而摩根大通和美国银行等大银行则跟随美国国债收益率下跌，股价下跌1.6%至1.9%。</blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Moderna(</b><b>MRNA</b><b>)</b>&nbsp;–&nbsp;Moderna stock surged 5% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote><b>现代（</b><b>MRNA</b><b>)</b>-Moderna宣布FDA授权在美国为18岁及以上成年人接种加强剂量的COVID-19疫苗后，股价在盘前交易中飙升5%。</blockquote></p><p> <b>Farfetch(FTCH)</b> – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.</p><p><blockquote><b>Farfetch(FTCH)</b>-这家在线奢侈时尚市场运营商公布季度亏损窄于预期且收入低于华尔街预测后，其股价在盘前暴跌22.1%。该公司还给出了弱于预期的调整后盈利指引。</blockquote></p><p> <b>Applied Materials(AMAT)</b> – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.</p><p><blockquote><b>应用材料公司(AMAT)</b>-应用材料公司调整后季度收益为每股1.94美元，比预期低一美分。这家半导体设备制造商的收入也低于预期。由于某些零部件供应短缺，应用材料公司也给出了弱于预期的本季度前景，其股价在盘前下跌6.2%。</blockquote></p><p> <b>Foot Locker(FL)</b> – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.</p><p><blockquote><b>Foot Locker(FL)</b>-运动鞋和服装零售商Foot Locker表示预计全球供应链限制将持续到本季度，盘前股价下跌7.1%。尽管Foot Locker最近一个季度的营收和利润都有所增长，而且可比商店销售额也好于预期，但还是出现了下滑。</blockquote></p><p> <b>Intuit(INTU)</b> – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.</p><p><blockquote><b>Intuit(INTU)</b>-Intuit最近一个季度调整后每股收益为1.53美元，远高于分析师预测的每股97美分。这家金融软件公司还公布了好于预期的收入，并给出了乐观的预测，因为它受益于去年年底收购的Credit Karma和上个月收购的MailChimp。其股价在盘前交易中飙升13%。</blockquote></p><p> <b>Ross Stores(ROST)</b> – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.</p><p><blockquote><b>罗斯商店(ROST)</b>–Ross Stores报告季度收益为每股1.09美元，高于78美分的普遍预期，收入也超出预期。然而，这家折扣零售商表示，它发现了严重的供应链问题，给假日购物季带来了不确定性，该股盘前下跌3.4%。</blockquote></p><p> <b>SoFi(SOFI)</b> – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.</p><p><blockquote><b>索菲(SOFI)</b>-SoFi在盘前下跌1.8%，此前有消息称投资者Chamath Palihapitiya出售了其在这家金融科技公司15%的股份，以帮助建立现金储备并为新投资提供资金。</blockquote></p><p> <b>Workday(WDAY)</b> – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.</p><p><blockquote><b>工作日(WDAY)</b>-Workday超出预期24美分，调整后季度收益为每股1.10美元，而这家人力资源软件制造商的收入因订阅收入增长更快而超出预期。然而，该公司表示，Covid-19大流行的影响将拖累来年的增长，该股在盘前交易中下跌7.5%。</blockquote></p><p> <b>Buckle(BKE)</b> – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.</p><p><blockquote><b>带扣(BKE)</b>-在发布乐观的季度收益报告后，这家时尚配饰零售商的股价在盘前上涨10.7%。该公司本季度每股收益1.26美元，超过92美分的普遍预期，收入也超过了华尔街的预测。</blockquote></p><p> <b>Dillard’s(DDS)</b> – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.</p><p><blockquote><b>迪拉德氏（DDS）</b>-该百货商店运营商宣布派发每股15美元的特别股息，将于12月15日向截至11月29日登记在册的股东支付，该公司股价在盘前交易中上涨3.2%。</blockquote></p><p></p><p> <b>Williams-Sonoma(WSM)</b> – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.</p><p><blockquote><b>威廉姆斯-索诺玛(WSM)</b>-Williams-Sonoma报告调整后季度收益为每股3.32美元，超过市场普遍预期的3.14美元。这家家居用品零售商的收入好于预期，并上调了全年预期，指出电子商务和各品牌实力强劲增长。Williams-Sonoma还报告了高于预期的本季度销售、一般和管理费用，该股在过去六个交易日中有五个交易日上涨后，盘前下跌7.1%。</blockquote></p><p> <b>Palo Alto Networks(PANW)</b> – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.</p><p><blockquote><b>帕洛阿尔托网络(PANW)</b>-帕洛阿尔托股价在盘前交易中上涨4.3%，扭转了该网络安全公司给出弱于预期的全年指引后出现的初步跌幅。Palo Alto最近一个季度的营收和利润超出了预期，调整后每股收益为1.64美元，而市场普遍预期为1.57美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.</p><p><blockquote>纳斯达克指数期货周五创下历史新高，因投资者在对总统乔·拜登1.75万亿美元支出法案的投票小幅推迟后寻求经济稳定的行业，而欧洲不断上升的COVID-19病例也削弱了市场情绪。</blockquote></p><p> S&amp;P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.</p><p><blockquote>标准普尔和道指期货下跌，跟踪银行、航空和其他经济敏感行业的损失。通胀上升和美联储紧缩政策的不确定性也使价值股的需求保持低位。</blockquote></p><p> At 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&amp;P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.</p><p><blockquote>美国东部时间上午7:55，道琼斯电子迷你指数下跌250点，即0.7%。标普500 e-mini下跌14点，即0.3%，纳斯达克100 e-mini上涨66.25点，即0.4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4d60c72fda7c9c4bcde12af36bdc2f99\" tg-width=\"414\" tg-height=\"185\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Shares of Alphabet Inc, Amazon.com&nbsp;and Microsoft Corp&nbsp;- stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.</p><p><blockquote>Alphabet公司、亚马逊公司和微软公司的股价自2020年以来基本上经受住了经济冲击，在盘前交易中上涨了0.3%至0.6%。</blockquote></p><p> Chipmaker Nvidia&nbsp;also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.</p><p><blockquote>芯片制造商英伟达(Nvidia)也提振了纳斯达克期货，在周三晚间公布强劲的季度业绩后，在大量交易中上涨1.4%。</blockquote></p><p> On the other hand, carriers Delta Air Lines, United Airlines&nbsp;and American Airlines, and cruiseliners Norwegian Cruise Line&nbsp;and Carnival Corp&nbsp;fell between 1.4% and 3%.</p><p><blockquote>另一方面，达美航空、联合航空和美国航空以及挪威邮轮和嘉年华公司的跌幅在1.4%至3%之间。</blockquote></p><p> Oil firms Exxon Mobil&nbsp;and Chevron Corp&nbsp;slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase &amp; Co&nbsp;and Bank of America&nbsp;were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.</p><p><blockquote>随着原油价格下跌，石油公司埃克森美孚和雪佛龙公司分别下跌2.7%和2.4%，而摩根大通和美国银行等大银行则跟随美国国债收益率下跌，股价下跌1.6%至1.9%。</blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Moderna(</b><b>MRNA</b><b>)</b>&nbsp;–&nbsp;Moderna stock surged 5% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote><b>现代（</b><b>MRNA</b><b>)</b>-Moderna宣布FDA授权在美国为18岁及以上成年人接种加强剂量的COVID-19疫苗后，股价在盘前交易中飙升5%。</blockquote></p><p> <b>Farfetch(FTCH)</b> – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.</p><p><blockquote><b>Farfetch(FTCH)</b>-这家在线奢侈时尚市场运营商公布季度亏损窄于预期且收入低于华尔街预测后，其股价在盘前暴跌22.1%。该公司还给出了弱于预期的调整后盈利指引。</blockquote></p><p> <b>Applied Materials(AMAT)</b> – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.</p><p><blockquote><b>应用材料公司(AMAT)</b>-应用材料公司调整后季度收益为每股1.94美元，比预期低一美分。这家半导体设备制造商的收入也低于预期。由于某些零部件供应短缺，应用材料公司也给出了弱于预期的本季度前景，其股价在盘前下跌6.2%。</blockquote></p><p> <b>Foot Locker(FL)</b> – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.</p><p><blockquote><b>Foot Locker(FL)</b>-运动鞋和服装零售商Foot Locker表示预计全球供应链限制将持续到本季度，盘前股价下跌7.1%。尽管Foot Locker最近一个季度的营收和利润都有所增长，而且可比商店销售额也好于预期，但还是出现了下滑。</blockquote></p><p> <b>Intuit(INTU)</b> – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.</p><p><blockquote><b>Intuit(INTU)</b>-Intuit最近一个季度调整后每股收益为1.53美元，远高于分析师预测的每股97美分。这家金融软件公司还公布了好于预期的收入，并给出了乐观的预测，因为它受益于去年年底收购的Credit Karma和上个月收购的MailChimp。其股价在盘前交易中飙升13%。</blockquote></p><p> <b>Ross Stores(ROST)</b> – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.</p><p><blockquote><b>罗斯商店(ROST)</b>–Ross Stores报告季度收益为每股1.09美元，高于78美分的普遍预期，收入也超出预期。然而，这家折扣零售商表示，它发现了严重的供应链问题，给假日购物季带来了不确定性，该股盘前下跌3.4%。</blockquote></p><p> <b>SoFi(SOFI)</b> – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.</p><p><blockquote><b>索菲(SOFI)</b>-SoFi在盘前下跌1.8%，此前有消息称投资者Chamath Palihapitiya出售了其在这家金融科技公司15%的股份，以帮助建立现金储备并为新投资提供资金。</blockquote></p><p> <b>Workday(WDAY)</b> – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.</p><p><blockquote><b>工作日(WDAY)</b>-Workday超出预期24美分，调整后季度收益为每股1.10美元，而这家人力资源软件制造商的收入因订阅收入增长更快而超出预期。然而，该公司表示，Covid-19大流行的影响将拖累来年的增长，该股在盘前交易中下跌7.5%。</blockquote></p><p> <b>Buckle(BKE)</b> – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.</p><p><blockquote><b>带扣(BKE)</b>-在发布乐观的季度收益报告后，这家时尚配饰零售商的股价在盘前上涨10.7%。该公司本季度每股收益1.26美元，超过92美分的普遍预期，收入也超过了华尔街的预测。</blockquote></p><p> <b>Dillard’s(DDS)</b> – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.</p><p><blockquote><b>迪拉德氏（DDS）</b>-该百货商店运营商宣布派发每股15美元的特别股息，将于12月15日向截至11月29日登记在册的股东支付，该公司股价在盘前交易中上涨3.2%。</blockquote></p><p></p><p> <b>Williams-Sonoma(WSM)</b> – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.</p><p><blockquote><b>威廉姆斯-索诺玛(WSM)</b>-Williams-Sonoma报告调整后季度收益为每股3.32美元，超过市场普遍预期的3.14美元。这家家居用品零售商的收入好于预期，并上调了全年预期，指出电子商务和各品牌实力强劲增长。Williams-Sonoma还报告了高于预期的本季度销售、一般和管理费用，该股在过去六个交易日中有五个交易日上涨后，盘前下跌7.1%。</blockquote></p><p> <b>Palo Alto Networks(PANW)</b> – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.</p><p><blockquote><b>帕洛阿尔托网络(PANW)</b>-帕洛阿尔托股价在盘前交易中上涨4.3%，扭转了该网络安全公司给出弱于预期的全年指引后出现的初步跌幅。Palo Alto最近一个季度的营收和利润超出了预期，调整后每股收益为1.64美元，而市场普遍预期为1.57美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SOFI":"SoFi Technologies Inc.","DDS":"狄乐百货","WSM":"Williams-Sonoma Inc","BKE":"巴克尔","MRNA":"Moderna, Inc.",".DJI":"道琼斯","ROST":"罗斯百货有限公司",".IXIC":"NASDAQ Composite","INTU":"财捷","AMAT":"应用材料"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156692377","content_text":"Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.\nS&P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.\nAt 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.\n\nShares of Alphabet Inc, Amazon.com and Microsoft Corp - stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.\nChipmaker Nvidia also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.\nOn the other hand, carriers Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp fell between 1.4% and 3%.\nOil firms Exxon Mobil and Chevron Corp slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase & Co and Bank of America were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.\nStocks making the biggest moves premarket:\nModerna(MRNA) – Moderna stock surged 5% in premarket trading after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.\nFarfetch(FTCH) – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.\nApplied Materials(AMAT) – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.\nFoot Locker(FL) – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.\nIntuit(INTU) – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.\nRoss Stores(ROST) – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.\nSoFi(SOFI) – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.\nWorkday(WDAY) – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.\nBuckle(BKE) – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.\nDillard’s(DDS) – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.\nWilliams-Sonoma(WSM) – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.\nPalo Alto Networks(PANW) – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.","news_type":1,"symbols_score_info":{"DDS":0.9,"INTU":0.9,"MRNA":0.9,".SPX":0.9,".IXIC":0.9,"FTCH":0.9,"NQmain":0.9,"ROST":0.9,".DJI":0.9,"ESmain":0.9,"FL":0.9,"WSM":0.9,"YMmain":0.9,"BKE":0.9,"SOFI":0.9,"AMAT":0.9}},"isVote":1,"tweetType":1,"viewCount":2635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878522213,"gmtCreate":1637209455774,"gmtModify":1637209455896,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878522213","repostId":"2184510828","repostType":4,"isVote":1,"tweetType":1,"viewCount":3272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871751218,"gmtCreate":1637115304345,"gmtModify":1637115304635,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871751218","repostId":"2184884068","repostType":4,"isVote":1,"tweetType":1,"viewCount":3467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871119592,"gmtCreate":1637035376520,"gmtModify":1637035410682,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871119592","repostId":"2183607933","repostType":4,"isVote":1,"tweetType":1,"viewCount":2319,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873263058,"gmtCreate":1636948706224,"gmtModify":1636948706371,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873263058","repostId":"2183536049","repostType":4,"isVote":1,"tweetType":1,"viewCount":2991,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873364041,"gmtCreate":1636860899303,"gmtModify":1636860899431,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873364041","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":2268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873365404,"gmtCreate":1636860890114,"gmtModify":1636860890234,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873365404","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":2140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879741253,"gmtCreate":1636779547878,"gmtModify":1636779547957,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879741253","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879801197,"gmtCreate":1636697653457,"gmtModify":1636697680660,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879801197","repostId":"1174358718","repostType":4,"isVote":1,"tweetType":1,"viewCount":656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870850562,"gmtCreate":1636603545125,"gmtModify":1636603545209,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870850562","repostId":"2182213053","repostType":4,"isVote":1,"tweetType":1,"viewCount":693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844782660,"gmtCreate":1636460736875,"gmtModify":1636460737156,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844782660","repostId":"1105674649","repostType":4,"repost":{"id":"1105674649","kind":"news","pubTimestamp":1636459675,"share":"https://www.laohu8.com/m/news/1105674649?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:07","market":"us","language":"en","title":"Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir预计2021财年收入增长40%；第三季度美国商业收入同比增长103%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1105674649","media":"businesswire","summary":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended","content":"<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.</p><p><blockquote>Palantir Technologies Inc.（纽约证券交易所股票代码：PLTR）今天公布了截至2021年9月30日的第三季度财务业绩。</blockquote></p><p> <b>Q3 2021 Highlights</b></p><p><blockquote><b>2021年第三季度亮点</b></blockquote></p><p> <ul>  <li>Total revenue grew 36% year-over-year to $392 million</li>  <li>Added 34 net new customers in Q3</li>  <li>Commercial customer count grew 46% quarter-over-quarter</li>  <li>US commercial revenue grew 103% year-over-year</li>  <li>Cash flow from operations of $101 million, representing a 26% margin</li>  <li>Adjusted free cash flow of $119 million, representing a 30% margin</li>  <li>Closed 54 deals of $1 million or more, of which:</li>  <li>Total remaining deal value grew 50% year-over-year to $3.6 billion</li>  <li>GAAP net loss per share, diluted of $(0.05)</li>  <li>Adjusted earnings per share, diluted of $0.04</li> </ul> <b>Q1-Q3 2021 Highlights</b></p><p><blockquote><ul><li>总收入同比增长36%至3.92亿美元</li><li>第三季度净新增34家新客户</li><li>商业客户数量环比增长46%</li><li>美国商业收入同比增长103%</li><li>运营现金流为1.01亿美元，利润率为26%</li><li>调整后自由现金流为1.19亿美元，利润率为30%</li><li>完成54笔100万美元或以上的交易，其中：</li><li>剩余交易总价值同比增长50%至36亿美元</li><li>GAAP稀释后每股净亏损为(0.05)美元</li><li>调整后稀释每股收益为0.04美元</li></ul><b>2021年第一季度至第三季度亮点</b></blockquote></p><p> <ul>  <li>Total revenue grew 44% year-over-year to $1.1 billion</li>  <li>Commercial customer count increased 135% since December 31, 2020</li>  <li>Cash flow from operations of $240 million, representing a 22% margin</li>  <li>Adjusted free cash flow of $320 million, representing a 29% margin</li> </ul> <b>Q3 2021 Financial Summary</b></p><p><blockquote><ul><li>总收入同比增长44%至11亿美元</li><li>自2020年12月31日以来，商业客户数量增加了135%</li><li>运营现金流为2.4亿美元，利润率为22%</li><li>调整后自由现金流为3.2亿美元，利润率为29%</li></ul><b>2021年第三季度财务摘要</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/658b280b0509d4e5fe970e5de61570e5\" tg-width=\"985\" tg-height=\"494\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <table>  <tbody>   <tr></tr>   <tr></tr>  </tbody> </table> <b>Outlook</b></p><p><blockquote><table><tbody><tr></tr><tr></tr></tbody></table><b>世界观</b></blockquote></p><p> For Q4 2021, we expect:</p><p><blockquote>对于2021年第四季度，我们预计：</blockquote></p><p> <ul>  <li>$418 million in revenue.</li>  <li>Adjusted operating margin of 22%.</li> </ul> For full year 2021:</p><p><blockquote><ul><li>收入4.18亿美元。</li><li>调整后营业利润率为22%。</li></ul>2021年全年：</blockquote></p><p> <ul>  <li>We expect revenue growth of 40% to $1.527 billion.</li>  <li>We are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.</li> </ul> Per long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:</p><p><blockquote><ul><li>我们预计收入增长40%至15.27亿美元。</li><li>我们将调整后自由现金流的预期从超过3亿美元上调至超过4亿美元。</li></ul>根据我们首席执行官Alex Karp提供的长期指导政策，我们继续期望：</blockquote></p><p> <ul>  <li>Annual revenue growth of 30% or greater for 2021 through 2025.</li> </ul> Palantir&nbsp;shares&nbsp;once&nbsp;rose&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/ca256a464d04c12064d041bcfbdf1049\" tg-width=\"894\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>2021年至2025年年收入增长30%或更多。</li></ul>Palantir股价在盘前交易中一度上涨近5%。</blockquote></p><p></p>","source":"lsy1584686423112","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir预计2021财年收入增长40%；第三季度美国商业收入同比增长103%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir预计2021财年收入增长40%；第三季度美国商业收入同比增长103%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">businesswire</strong><span class=\"h-time small\">2021-11-09 20:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.</p><p><blockquote>Palantir Technologies Inc.（纽约证券交易所股票代码：PLTR）今天公布了截至2021年9月30日的第三季度财务业绩。</blockquote></p><p> <b>Q3 2021 Highlights</b></p><p><blockquote><b>2021年第三季度亮点</b></blockquote></p><p> <ul>  <li>Total revenue grew 36% year-over-year to $392 million</li>  <li>Added 34 net new customers in Q3</li>  <li>Commercial customer count grew 46% quarter-over-quarter</li>  <li>US commercial revenue grew 103% year-over-year</li>  <li>Cash flow from operations of $101 million, representing a 26% margin</li>  <li>Adjusted free cash flow of $119 million, representing a 30% margin</li>  <li>Closed 54 deals of $1 million or more, of which:</li>  <li>Total remaining deal value grew 50% year-over-year to $3.6 billion</li>  <li>GAAP net loss per share, diluted of $(0.05)</li>  <li>Adjusted earnings per share, diluted of $0.04</li> </ul> <b>Q1-Q3 2021 Highlights</b></p><p><blockquote><ul><li>总收入同比增长36%至3.92亿美元</li><li>第三季度净新增34家新客户</li><li>商业客户数量环比增长46%</li><li>美国商业收入同比增长103%</li><li>运营现金流为1.01亿美元，利润率为26%</li><li>调整后自由现金流为1.19亿美元，利润率为30%</li><li>完成54笔100万美元或以上的交易，其中：</li><li>剩余交易总价值同比增长50%至36亿美元</li><li>GAAP稀释后每股净亏损为(0.05)美元</li><li>调整后稀释每股收益为0.04美元</li></ul><b>2021年第一季度至第三季度亮点</b></blockquote></p><p> <ul>  <li>Total revenue grew 44% year-over-year to $1.1 billion</li>  <li>Commercial customer count increased 135% since December 31, 2020</li>  <li>Cash flow from operations of $240 million, representing a 22% margin</li>  <li>Adjusted free cash flow of $320 million, representing a 29% margin</li> </ul> <b>Q3 2021 Financial Summary</b></p><p><blockquote><ul><li>总收入同比增长44%至11亿美元</li><li>自2020年12月31日以来，商业客户数量增加了135%</li><li>运营现金流为2.4亿美元，利润率为22%</li><li>调整后自由现金流为3.2亿美元，利润率为29%</li></ul><b>2021年第三季度财务摘要</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/658b280b0509d4e5fe970e5de61570e5\" tg-width=\"985\" tg-height=\"494\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <table>  <tbody>   <tr></tr>   <tr></tr>  </tbody> </table> <b>Outlook</b></p><p><blockquote><table><tbody><tr></tr><tr></tr></tbody></table><b>世界观</b></blockquote></p><p> For Q4 2021, we expect:</p><p><blockquote>对于2021年第四季度，我们预计：</blockquote></p><p> <ul>  <li>$418 million in revenue.</li>  <li>Adjusted operating margin of 22%.</li> </ul> For full year 2021:</p><p><blockquote><ul><li>收入4.18亿美元。</li><li>调整后营业利润率为22%。</li></ul>2021年全年：</blockquote></p><p> <ul>  <li>We expect revenue growth of 40% to $1.527 billion.</li>  <li>We are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.</li> </ul> Per long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:</p><p><blockquote><ul><li>我们预计收入增长40%至15.27亿美元。</li><li>我们将调整后自由现金流的预期从超过3亿美元上调至超过4亿美元。</li></ul>根据我们首席执行官Alex Karp提供的长期指导政策，我们继续期望：</blockquote></p><p> <ul>  <li>Annual revenue growth of 30% or greater for 2021 through 2025.</li> </ul> Palantir&nbsp;shares&nbsp;once&nbsp;rose&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/ca256a464d04c12064d041bcfbdf1049\" tg-width=\"894\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>2021年至2025年年收入增长30%或更多。</li></ul>Palantir股价在盘前交易中一度上涨近5%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY\">businesswire</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105674649","content_text":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.\nQ3 2021 Highlights\n\nTotal revenue grew 36% year-over-year to $392 million\nAdded 34 net new customers in Q3\nCommercial customer count grew 46% quarter-over-quarter\nUS commercial revenue grew 103% year-over-year\nCash flow from operations of $101 million, representing a 26% margin\nAdjusted free cash flow of $119 million, representing a 30% margin\nClosed 54 deals of $1 million or more, of which:\nTotal remaining deal value grew 50% year-over-year to $3.6 billion\nGAAP net loss per share, diluted of $(0.05)\nAdjusted earnings per share, diluted of $0.04\n\nQ1-Q3 2021 Highlights\n\nTotal revenue grew 44% year-over-year to $1.1 billion\nCommercial customer count increased 135% since December 31, 2020\nCash flow from operations of $240 million, representing a 22% margin\nAdjusted free cash flow of $320 million, representing a 29% margin\n\nQ3 2021 Financial Summary\n\n\n\n\n\n\n\nOutlook\nFor Q4 2021, we expect:\n\n$418 million in revenue.\nAdjusted operating margin of 22%.\n\nFor full year 2021:\n\nWe expect revenue growth of 40% to $1.527 billion.\nWe are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.\n\nPer long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:\n\nAnnual revenue growth of 30% or greater for 2021 through 2025.\n\nPalantir shares once rose nearly 5% in premarket trading.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":948,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845598528,"gmtCreate":1636348034306,"gmtModify":1636348034554,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845598528","repostId":"2181284457","repostType":4,"isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845109912,"gmtCreate":1636295020855,"gmtModify":1636295021155,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/845109912","repostId":"2181409167","repostType":4,"repost":{"id":"2181409167","kind":"news","pubTimestamp":1636262820,"share":"https://www.laohu8.com/m/news/2181409167?lang=zh_CN&edition=full","pubTime":"2021-11-07 13:27","market":"fut","language":"en","title":"US to Opec+: ‘This isn’t the end’ of effort to ease oil prices<blockquote>美国对欧佩克+：缓解油价努力的“这还不是结束”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2181409167","media":"BusinessDay","summary":"Biden wants the cartel to pump more oil to bring down prices and keep the post-Covid economic recovery on course","content":"<p><div> The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t...</p><p><blockquote><div>美国本周警告称，石油输出国组织+未能向全球市场注入更多石油，有可能损害世界经济复苏，这表明其缓解高原油价格的努力没有成功...</div></blockquote></p><p>  <a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">网页连接</a></blockquote></p><p></p>","source":"businessday_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US to Opec+: ‘This isn’t the end’ of effort to ease oil prices<blockquote>美国对欧佩克+：缓解油价努力的“这还不是结束”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS to Opec+: ‘This isn’t the end’ of effort to ease oil prices<blockquote>美国对欧佩克+：缓解油价努力的“这还不是结束”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">BusinessDay</strong><span class=\"h-time small\">2021-11-07 13:27</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t...</p><p><blockquote><div>美国本周警告称，石油输出国组织+未能向全球市场注入更多石油，有可能损害世界经济复苏，这表明其缓解高原油价格的努力没有成功...</div></blockquote></p><p>  <a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">BusinessDay</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181409167","content_text":"The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t over.Hours after Saudi Arabia and its allies in Opec+ — the 14 members of the Organisation of Petroleum Exporting Countries plus 10 non-members, including Russia — approved a 400,000 barrel-a-day output hike for December, the White House reiterated that it will consider “the full range of tools” to protect the economy.Other major consumers also say the Opec+ decision, at a meeting of the cartel this week, is not enough to sustain the post-Covid economic recovery, with the US asking for as much as double that amount. “They have the capacity and the power now to act and make sure this critical moment of global recovery is not impaired,” White House spokesperson Karine Jean-Pierre said.The US operates in “a competitive free market system”, she said, and Opec+ “is what impacts global oil prices, which is what has an effect on gas [petrol] prices at home”.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846591501,"gmtCreate":1636093399184,"gmtModify":1636093399410,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846591501","repostId":"1128227989","repostType":4,"repost":{"id":"1128227989","kind":"news","pubTimestamp":1636067303,"share":"https://www.laohu8.com/m/news/1128227989?lang=zh_CN&edition=full","pubTime":"2021-11-05 07:08","market":"us","language":"en","title":"S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128227989","media":"Reuters","summary":" - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.Financials dropped 1","content":"<p>(Reuters) - The S&amp;P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>（路透社）-标普500和纳斯达克周四上涨，将收盘纪录高位连涨至六个交易日，因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后，芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase &amp; Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌，结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&amp;P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%，其中大部分是标普500板块，因美国国债收益率下跌，在美联储表示不急于加息的第二天，市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示：“市场的增长方今天看到了更积极的结果，因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模，市场总体上一直在为更高的收益率做准备。当我们今天走进来时，这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&amp;P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点，跌幅0.09%，至36,124.23点；标普500上涨19.49点，跌幅0.42%，至4,680.06点；纳斯达克综合指数上涨128.72点，跌幅0.81%，至15,940.31点。</blockquote></p><p> The S&amp;P 500 growth index rose 1.2% while the S&amp;P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%，标普500价值指数下跌0.5%。</blockquote></p><p> Among S&amp;P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中，科技和非必需消费品领涨，均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%，该公司预测本季度利润和收入好于预期，原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%，英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据，约有420家公司发布了财报，预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示：“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司，而市场正在惩罚那些本季度未达到预期的公司，也许更重要的是，这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&amp;P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%，该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元，并努力灌装和分销小瓶，以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块，该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至近20个月来的最低水平，表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1；在纳斯达克，1.24比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低；纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手，高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-05 07:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - The S&amp;P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>（路透社）-标普500和纳斯达克周四上涨，将收盘纪录高位连涨至六个交易日，因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后，芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase &amp; Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌，结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&amp;P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%，其中大部分是标普500板块，因美国国债收益率下跌，在美联储表示不急于加息的第二天，市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示：“市场的增长方今天看到了更积极的结果，因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模，市场总体上一直在为更高的收益率做准备。当我们今天走进来时，这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&amp;P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点，跌幅0.09%，至36,124.23点；标普500上涨19.49点，跌幅0.42%，至4,680.06点；纳斯达克综合指数上涨128.72点，跌幅0.81%，至15,940.31点。</blockquote></p><p> The S&amp;P 500 growth index rose 1.2% while the S&amp;P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%，标普500价值指数下跌0.5%。</blockquote></p><p> Among S&amp;P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中，科技和非必需消费品领涨，均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%，该公司预测本季度利润和收入好于预期，原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%，英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据，约有420家公司发布了财报，预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示：“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司，而市场正在惩罚那些本季度未达到预期的公司，也许更重要的是，这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&amp;P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%，该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元，并努力灌装和分销小瓶，以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块，该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至近20个月来的最低水平，表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1；在纳斯达克，1.24比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低；纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手，高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF博时","OEF":"标普100指数ETF-iShares","OEX":"标普100",".IXIC":"NASDAQ Composite","IVV":"标普500ETF-iShares","SPXU":"三倍做空标普500ETF-ProShares","SSO":"2倍做多标普500ETF-ProShares","SDS":"两倍做空标普500 ETF-ProShares",".SPX":"S&P 500 Index","SH":"做空标普500-Proshares",".DJI":"道琼斯","UPRO":"三倍做多标普500ETF-ProShares"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128227989","content_text":"(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.\nThe Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.\nFinancials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.\n“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\n“The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”\nThe Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.\nThe S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.\nAmong S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.\nQualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.\nThe Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.\n“The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.\n“The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”\nModerna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.\nData showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.\nThe S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.\nAbout 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,"OEX":0.9,"SH":0.9,".SPX":0.9,"ESmain":0.9,".IXIC":0.9,"IVV":0.9,"SSO":0.9,"UPRO":0.9,"SPXU":0.9,"SDS":0.9,".DJI":0.9,"OEF":0.9}},"isVote":1,"tweetType":1,"viewCount":867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846306577,"gmtCreate":1636044717819,"gmtModify":1636044718035,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846306577","repostId":"1198103703","repostType":4,"isVote":1,"tweetType":1,"viewCount":879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843635838,"gmtCreate":1635822582344,"gmtModify":1635822582462,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843635838","repostId":"2180209403","repostType":4,"isVote":1,"tweetType":1,"viewCount":789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849553061,"gmtCreate":1635768819563,"gmtModify":1635768819713,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087701475296490","idStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849553061","repostId":"1121087038","repostType":4,"isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":872811057,"gmtCreate":1637471923847,"gmtModify":1637471923971,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872811057","repostId":"1156888846","repostType":4,"repost":{"id":"1156888846","kind":"news","pubTimestamp":1637465976,"share":"https://www.laohu8.com/m/news/1156888846?lang=zh_CN&edition=full","pubTime":"2021-11-21 11:39","market":"us","language":"en","title":"Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156888846","media":"Benzinga","summary":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shel","content":"<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","RIVN":"Rivian Automotive, Inc."},"source_url":"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156888846","content_text":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether.\nWhat Happened:As Ford steps on the gas on its EV transition, the Detroit-based automaker has decided to abandon it plans to jointly develop an EV with Rivian, CEO Jim Farley said in an interview with Automotive News.\nFarley said Ford expects to produce 600,000 vehicles per year by the end of 2023.\nWhen Ford initially invested $500 million in Rivian in 2019, it envisaged developing a Ford branded EV that will come with Rivian's skateboard powertrain. In early 2020, the companies said they are shelving the plans for a Lincoln-branded EV but would go ahead with an alternative vehicle based on Rivian technology.\nThe Ford CEO suggested in the interview that the company is now increasingly confident in competing in the EV space by itself. Another handicap that forced the going-solo decision was the complexities involved in integrating the hardware and software together.\nWhy It's Important:Rivian shares debuted on Wall Street on Nov. 10 following aninitial public offeringat a bumper valuation of over $100 billion. The company's strong debut and the subsequent run up in shares have raised eyebrows over its valuation which has taken it past the market capitalization of legacy U.S. automakers, including Ford.\nRivian's product pipeline consists of RIT, an EV pickup truck, which it began delivering to customers in September. As of Oct. 30, the company produced 180 R1Ts and delivered 156 R1Ts, with the bulk of them going to the company's employees.\nThe company noted that at the end of October, it had preorders of about 55,400 R1Ts and R1Ss. It expects to fill the preorder backlog by the end of 2023.\nFord, for its part, has doubled on itsEV strategyand invested big dollars into its transition toward EVs.\n\"We respect Rivian and have had extensive exploratory discussions with them, however, both sides have agreed not to pursue any kind of joint vehicle development or platform sharing,\" Ford said in an emailed statement to media.\nRivian, meanwhile, confirmed that it is a mutual decision to focus on each of their own projects and deliveries, given Ford has scaled its own EV strategy and demand for Rivian vehicles has grown.\n\"Our relationship with Ford is an important part of our journey, and Ford remains an investor and ally on our shared path to an electrified future\" a Rivian spokesperson said.\nRivian closed Friday's session up 4.23% at $128.60, while Ford closed down 0.87% at $19.39.","news_type":1,"symbols_score_info":{"RIVN":0.9,"F":0.9}},"isVote":1,"tweetType":1,"viewCount":3666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":893089005,"gmtCreate":1628220936107,"gmtModify":1633752460989,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/893089005","repostId":"1155519509","repostType":4,"isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":876517849,"gmtCreate":1637331621619,"gmtModify":1637331621888,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876517849","repostId":"1156692377","repostType":4,"repost":{"id":"1156692377","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637326873,"share":"https://www.laohu8.com/m/news/1156692377?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156692377","media":"Tiger Newspress","summary":"Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors aft","content":"<p>Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.</p><p><blockquote>纳斯达克指数期货周五创下历史新高，因投资者在对总统乔·拜登1.75万亿美元支出法案的投票小幅推迟后寻求经济稳定的行业，而欧洲不断上升的COVID-19病例也削弱了市场情绪。</blockquote></p><p> S&amp;P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.</p><p><blockquote>标准普尔和道指期货下跌，跟踪银行、航空和其他经济敏感行业的损失。通胀上升和美联储紧缩政策的不确定性也使价值股的需求保持低位。</blockquote></p><p> At 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&amp;P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.</p><p><blockquote>美国东部时间上午7:55，道琼斯电子迷你指数下跌250点，即0.7%。标普500 e-mini下跌14点，即0.3%，纳斯达克100 e-mini上涨66.25点，即0.4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4d60c72fda7c9c4bcde12af36bdc2f99\" tg-width=\"414\" tg-height=\"185\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Shares of Alphabet Inc, Amazon.com&nbsp;and Microsoft Corp&nbsp;- stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.</p><p><blockquote>Alphabet公司、亚马逊公司和微软公司的股价自2020年以来基本上经受住了经济冲击，在盘前交易中上涨了0.3%至0.6%。</blockquote></p><p> Chipmaker Nvidia&nbsp;also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.</p><p><blockquote>芯片制造商英伟达(Nvidia)也提振了纳斯达克期货，在周三晚间公布强劲的季度业绩后，在大量交易中上涨1.4%。</blockquote></p><p> On the other hand, carriers Delta Air Lines, United Airlines&nbsp;and American Airlines, and cruiseliners Norwegian Cruise Line&nbsp;and Carnival Corp&nbsp;fell between 1.4% and 3%.</p><p><blockquote>另一方面，达美航空、联合航空和美国航空以及挪威邮轮和嘉年华公司的跌幅在1.4%至3%之间。</blockquote></p><p> Oil firms Exxon Mobil&nbsp;and Chevron Corp&nbsp;slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase &amp; Co&nbsp;and Bank of America&nbsp;were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.</p><p><blockquote>随着原油价格下跌，石油公司埃克森美孚和雪佛龙公司分别下跌2.7%和2.4%，而摩根大通和美国银行等大银行则跟随美国国债收益率下跌，股价下跌1.6%至1.9%。</blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Moderna(</b><b>MRNA</b><b>)</b>&nbsp;–&nbsp;Moderna stock surged 5% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote><b>现代（</b><b>MRNA</b><b>)</b>-Moderna宣布FDA授权在美国为18岁及以上成年人接种加强剂量的COVID-19疫苗后，股价在盘前交易中飙升5%。</blockquote></p><p> <b>Farfetch(FTCH)</b> – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.</p><p><blockquote><b>Farfetch(FTCH)</b>-这家在线奢侈时尚市场运营商公布季度亏损窄于预期且收入低于华尔街预测后，其股价在盘前暴跌22.1%。该公司还给出了弱于预期的调整后盈利指引。</blockquote></p><p> <b>Applied Materials(AMAT)</b> – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.</p><p><blockquote><b>应用材料公司(AMAT)</b>-应用材料公司调整后季度收益为每股1.94美元，比预期低一美分。这家半导体设备制造商的收入也低于预期。由于某些零部件供应短缺，应用材料公司也给出了弱于预期的本季度前景，其股价在盘前下跌6.2%。</blockquote></p><p> <b>Foot Locker(FL)</b> – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.</p><p><blockquote><b>Foot Locker(FL)</b>-运动鞋和服装零售商Foot Locker表示预计全球供应链限制将持续到本季度，盘前股价下跌7.1%。尽管Foot Locker最近一个季度的营收和利润都有所增长，而且可比商店销售额也好于预期，但还是出现了下滑。</blockquote></p><p> <b>Intuit(INTU)</b> – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.</p><p><blockquote><b>Intuit(INTU)</b>-Intuit最近一个季度调整后每股收益为1.53美元，远高于分析师预测的每股97美分。这家金融软件公司还公布了好于预期的收入，并给出了乐观的预测，因为它受益于去年年底收购的Credit Karma和上个月收购的MailChimp。其股价在盘前交易中飙升13%。</blockquote></p><p> <b>Ross Stores(ROST)</b> – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.</p><p><blockquote><b>罗斯商店(ROST)</b>–Ross Stores报告季度收益为每股1.09美元，高于78美分的普遍预期，收入也超出预期。然而，这家折扣零售商表示，它发现了严重的供应链问题，给假日购物季带来了不确定性，该股盘前下跌3.4%。</blockquote></p><p> <b>SoFi(SOFI)</b> – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.</p><p><blockquote><b>索菲(SOFI)</b>-SoFi在盘前下跌1.8%，此前有消息称投资者Chamath Palihapitiya出售了其在这家金融科技公司15%的股份，以帮助建立现金储备并为新投资提供资金。</blockquote></p><p> <b>Workday(WDAY)</b> – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.</p><p><blockquote><b>工作日(WDAY)</b>-Workday超出预期24美分，调整后季度收益为每股1.10美元，而这家人力资源软件制造商的收入因订阅收入增长更快而超出预期。然而，该公司表示，Covid-19大流行的影响将拖累来年的增长，该股在盘前交易中下跌7.5%。</blockquote></p><p> <b>Buckle(BKE)</b> – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.</p><p><blockquote><b>带扣(BKE)</b>-在发布乐观的季度收益报告后，这家时尚配饰零售商的股价在盘前上涨10.7%。该公司本季度每股收益1.26美元，超过92美分的普遍预期，收入也超过了华尔街的预测。</blockquote></p><p> <b>Dillard’s(DDS)</b> – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.</p><p><blockquote><b>迪拉德氏（DDS）</b>-该百货商店运营商宣布派发每股15美元的特别股息，将于12月15日向截至11月29日登记在册的股东支付，该公司股价在盘前交易中上涨3.2%。</blockquote></p><p></p><p> <b>Williams-Sonoma(WSM)</b> – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.</p><p><blockquote><b>威廉姆斯-索诺玛(WSM)</b>-Williams-Sonoma报告调整后季度收益为每股3.32美元，超过市场普遍预期的3.14美元。这家家居用品零售商的收入好于预期，并上调了全年预期，指出电子商务和各品牌实力强劲增长。Williams-Sonoma还报告了高于预期的本季度销售、一般和管理费用，该股在过去六个交易日中有五个交易日上涨后，盘前下跌7.1%。</blockquote></p><p> <b>Palo Alto Networks(PANW)</b> – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.</p><p><blockquote><b>帕洛阿尔托网络(PANW)</b>-帕洛阿尔托股价在盘前交易中上涨4.3%，扭转了该网络安全公司给出弱于预期的全年指引后出现的初步跌幅。Palo Alto最近一个季度的营收和利润超出了预期，调整后每股收益为1.64美元，而市场普遍预期为1.57美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday<blockquote>周五美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.</p><p><blockquote>纳斯达克指数期货周五创下历史新高，因投资者在对总统乔·拜登1.75万亿美元支出法案的投票小幅推迟后寻求经济稳定的行业，而欧洲不断上升的COVID-19病例也削弱了市场情绪。</blockquote></p><p> S&amp;P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.</p><p><blockquote>标准普尔和道指期货下跌，跟踪银行、航空和其他经济敏感行业的损失。通胀上升和美联储紧缩政策的不确定性也使价值股的需求保持低位。</blockquote></p><p> At 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&amp;P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.</p><p><blockquote>美国东部时间上午7:55，道琼斯电子迷你指数下跌250点，即0.7%。标普500 e-mini下跌14点，即0.3%，纳斯达克100 e-mini上涨66.25点，即0.4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4d60c72fda7c9c4bcde12af36bdc2f99\" tg-width=\"414\" tg-height=\"185\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Shares of Alphabet Inc, Amazon.com&nbsp;and Microsoft Corp&nbsp;- stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.</p><p><blockquote>Alphabet公司、亚马逊公司和微软公司的股价自2020年以来基本上经受住了经济冲击，在盘前交易中上涨了0.3%至0.6%。</blockquote></p><p> Chipmaker Nvidia&nbsp;also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.</p><p><blockquote>芯片制造商英伟达(Nvidia)也提振了纳斯达克期货，在周三晚间公布强劲的季度业绩后，在大量交易中上涨1.4%。</blockquote></p><p> On the other hand, carriers Delta Air Lines, United Airlines&nbsp;and American Airlines, and cruiseliners Norwegian Cruise Line&nbsp;and Carnival Corp&nbsp;fell between 1.4% and 3%.</p><p><blockquote>另一方面，达美航空、联合航空和美国航空以及挪威邮轮和嘉年华公司的跌幅在1.4%至3%之间。</blockquote></p><p> Oil firms Exxon Mobil&nbsp;and Chevron Corp&nbsp;slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase &amp; Co&nbsp;and Bank of America&nbsp;were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.</p><p><blockquote>随着原油价格下跌，石油公司埃克森美孚和雪佛龙公司分别下跌2.7%和2.4%，而摩根大通和美国银行等大银行则跟随美国国债收益率下跌，股价下跌1.6%至1.9%。</blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Moderna(</b><b>MRNA</b><b>)</b>&nbsp;–&nbsp;Moderna stock surged 5% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p><p><blockquote><b>现代（</b><b>MRNA</b><b>)</b>-Moderna宣布FDA授权在美国为18岁及以上成年人接种加强剂量的COVID-19疫苗后，股价在盘前交易中飙升5%。</blockquote></p><p> <b>Farfetch(FTCH)</b> – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.</p><p><blockquote><b>Farfetch(FTCH)</b>-这家在线奢侈时尚市场运营商公布季度亏损窄于预期且收入低于华尔街预测后，其股价在盘前暴跌22.1%。该公司还给出了弱于预期的调整后盈利指引。</blockquote></p><p> <b>Applied Materials(AMAT)</b> – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.</p><p><blockquote><b>应用材料公司(AMAT)</b>-应用材料公司调整后季度收益为每股1.94美元，比预期低一美分。这家半导体设备制造商的收入也低于预期。由于某些零部件供应短缺，应用材料公司也给出了弱于预期的本季度前景，其股价在盘前下跌6.2%。</blockquote></p><p> <b>Foot Locker(FL)</b> – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.</p><p><blockquote><b>Foot Locker(FL)</b>-运动鞋和服装零售商Foot Locker表示预计全球供应链限制将持续到本季度，盘前股价下跌7.1%。尽管Foot Locker最近一个季度的营收和利润都有所增长，而且可比商店销售额也好于预期，但还是出现了下滑。</blockquote></p><p> <b>Intuit(INTU)</b> – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.</p><p><blockquote><b>Intuit(INTU)</b>-Intuit最近一个季度调整后每股收益为1.53美元，远高于分析师预测的每股97美分。这家金融软件公司还公布了好于预期的收入，并给出了乐观的预测，因为它受益于去年年底收购的Credit Karma和上个月收购的MailChimp。其股价在盘前交易中飙升13%。</blockquote></p><p> <b>Ross Stores(ROST)</b> – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.</p><p><blockquote><b>罗斯商店(ROST)</b>–Ross Stores报告季度收益为每股1.09美元，高于78美分的普遍预期，收入也超出预期。然而，这家折扣零售商表示，它发现了严重的供应链问题，给假日购物季带来了不确定性，该股盘前下跌3.4%。</blockquote></p><p> <b>SoFi(SOFI)</b> – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.</p><p><blockquote><b>索菲(SOFI)</b>-SoFi在盘前下跌1.8%，此前有消息称投资者Chamath Palihapitiya出售了其在这家金融科技公司15%的股份，以帮助建立现金储备并为新投资提供资金。</blockquote></p><p> <b>Workday(WDAY)</b> – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.</p><p><blockquote><b>工作日(WDAY)</b>-Workday超出预期24美分，调整后季度收益为每股1.10美元，而这家人力资源软件制造商的收入因订阅收入增长更快而超出预期。然而，该公司表示，Covid-19大流行的影响将拖累来年的增长，该股在盘前交易中下跌7.5%。</blockquote></p><p> <b>Buckle(BKE)</b> – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.</p><p><blockquote><b>带扣(BKE)</b>-在发布乐观的季度收益报告后，这家时尚配饰零售商的股价在盘前上涨10.7%。该公司本季度每股收益1.26美元，超过92美分的普遍预期，收入也超过了华尔街的预测。</blockquote></p><p> <b>Dillard’s(DDS)</b> – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.</p><p><blockquote><b>迪拉德氏（DDS）</b>-该百货商店运营商宣布派发每股15美元的特别股息，将于12月15日向截至11月29日登记在册的股东支付，该公司股价在盘前交易中上涨3.2%。</blockquote></p><p></p><p> <b>Williams-Sonoma(WSM)</b> – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.</p><p><blockquote><b>威廉姆斯-索诺玛(WSM)</b>-Williams-Sonoma报告调整后季度收益为每股3.32美元，超过市场普遍预期的3.14美元。这家家居用品零售商的收入好于预期，并上调了全年预期，指出电子商务和各品牌实力强劲增长。Williams-Sonoma还报告了高于预期的本季度销售、一般和管理费用，该股在过去六个交易日中有五个交易日上涨后，盘前下跌7.1%。</blockquote></p><p> <b>Palo Alto Networks(PANW)</b> – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.</p><p><blockquote><b>帕洛阿尔托网络(PANW)</b>-帕洛阿尔托股价在盘前交易中上涨4.3%，扭转了该网络安全公司给出弱于预期的全年指引后出现的初步跌幅。Palo Alto最近一个季度的营收和利润超出了预期，调整后每股收益为1.64美元，而市场普遍预期为1.57美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SOFI":"SoFi Technologies Inc.","DDS":"狄乐百货","WSM":"Williams-Sonoma Inc","BKE":"巴克尔","MRNA":"Moderna, Inc.",".DJI":"道琼斯","ROST":"罗斯百货有限公司",".IXIC":"NASDAQ Composite","INTU":"财捷","AMAT":"应用材料"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156692377","content_text":"Nasdaq index futures hit a record high on Friday as investors sought economically stable sectors after a small delay in voting on President Joe Biden's $1.75 trillion spending bill, while rising COVID-19 cases in Europe also dented sentiment.\nS&P and Dow futures fell tracking losses in banks, airlines, and other economically sensitive sectors. Uncertainty over rising inflation and the Federal Reserve's tightening also kept demand for value stocks low.\nAt 7:55 a.m. ET, Dow e-minis were down 250 points, or 0.7%. S&P 500 e-minis were down 14 points, or 0.3% and Nasdaq 100 e-minis were up 66.25 points, or 0.4%.\n\nShares of Alphabet Inc, Amazon.com and Microsoft Corp - stocks which have largely persevered through economic shocks since 2020, rose between 0.3% and 0.6% in premarket trade.\nChipmaker Nvidia also boosted Nasdaq futures, rising 1.4% in heavy trade after posting strong quarterly results late Wednesday.\nOn the other hand, carriers Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp fell between 1.4% and 3%.\nOil firms Exxon Mobil and Chevron Corp slipped 2.7% and 2.4% as crude prices sank, while big banks including JPMorgan Chase & Co and Bank of America were down between 1.6% and 1.9%, tracking a fall in U.S. Treasury yields.\nStocks making the biggest moves premarket:\nModerna(MRNA) – Moderna stock surged 5% in premarket trading after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.\nFarfetch(FTCH) – The online luxury fashion marketplace operator’s shares plunged 22.1% in the premarket after it reported a narrower-than-expected quarterly loss and saw revenue fall short of Wall Street forecasts. The company also gave weaker-than-expected adjusted earnings guidance.\nApplied Materials(AMAT) – Applied Materials came in a penny shy of estimates with adjusted quarterly earnings of $1.94 per share. The semiconductor equipment maker’s revenue fell short of forecasts as well. Applied Materials also gave a weaker-than-expected current-quarter outlook amid supply shortages of certain components, and its stock tumbled 6.2% in premarket action.\nFoot Locker(FL) – Foot Locker slid 7.1% in the premarket after the athletic footwear and apparel retailer said it expects global supply chain constraints to persist through this quarter. The slide comes despite a beat on both the top and bottom lines for Foot Locker’s most recent quarter, as well as better-than-expected comparable store sales.\nIntuit(INTU) – Intuit earned an adjusted $1.53 per share for its latest quarter, well above analyst forecasts for a profit of 97 cents per share. The financial software firm also reported better-than-expected revenue and gave an upbeat forecast as it benefits from its acquisition of Credit Karma late last year and MailChimp last month. Its stock surged 13% in premarket trading.\nRoss Stores(ROST) – Ross Stores reported quarterly earnings of $1.09 per share, topping the 78-cent consensus estimate, with revenue also beating forecasts. However, the discount retailer said it was seeing significant supply chain issues, causing uncertainty heading into the holiday shopping season, and the stock slid 3.4% in the premarket.\nSoFi(SOFI) – SoFi fell 1.8% in premarket action following news that investor Chamath Palihapitiya sold 15% of his stake in the fintech firm to help build his cash reserves and fund new investments.\nWorkday(WDAY) – Workday beat estimates by 24 cents with adjusted quarterly earnings of $1.10 per share, while the maker of human resources software saw revenue top estimates amid faster growth in subscription revenue. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year, and the stock tumbled 7.5% in premarket trading.\nBuckle(BKE) – The fashion accessories retailer’s stock rallied 10.7% in the premarket following an upbeat quarterly earnings report. The company earned $1.26 per share for the quarter, beating the 92-cent consensus estimate, with revenue also topping Street projections.\nDillard’s(DDS) – The department store operator’s stock added 3.2% in premarket trading after the company announced a $15 per share special dividend, payable on December 15 to shareholders of record as of November 29.\nWilliams-Sonoma(WSM) – Williams-Sonoma reported adjusted quarterly earnings of $3.32 per share, beating the consensus estimate of $3.14. The housewares retailer saw better-than-expected revenue and raised its full-year forecast, noting a strong jump in e-commerce and strength across its brands. Williams-Sonoma also reported higher-than-expected selling, general and administrative expenses during the quarter, and the stock fell 7.1% in the premarket after rising in five of the past six sessions.\nPalo Alto Networks(PANW) – Palo Alto shares jumped 4.3% in premarket trading, reversing initial losses that occurred after the cybersecurity firm gave weaker-than-expected full-year guidance. Palo Alto beat forecasts on the top and bottom lines for its most recent quarter, earning an adjusted $1.64 per share compared with a consensus estimate of $1.57.","news_type":1,"symbols_score_info":{"DDS":0.9,"INTU":0.9,"MRNA":0.9,".SPX":0.9,".IXIC":0.9,"FTCH":0.9,"NQmain":0.9,"ROST":0.9,".DJI":0.9,"ESmain":0.9,"FL":0.9,"WSM":0.9,"YMmain":0.9,"BKE":0.9,"SOFI":0.9,"AMAT":0.9}},"isVote":1,"tweetType":1,"viewCount":2635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878522213,"gmtCreate":1637209455774,"gmtModify":1637209455896,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878522213","repostId":"2184510828","repostType":4,"isVote":1,"tweetType":1,"viewCount":3272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853192954,"gmtCreate":1634778199261,"gmtModify":1634778199479,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/853192954","repostId":"2177314294","repostType":4,"isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823351024,"gmtCreate":1633588197968,"gmtModify":1633588198111,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823351024","repostId":"2173948607","repostType":4,"repost":{"id":"2173948607","kind":"highlight","pubTimestamp":1633570746,"share":"https://www.laohu8.com/m/news/2173948607?lang=zh_CN&edition=full","pubTime":"2021-10-07 09:39","market":"us","language":"en","title":"Here are 10 'high conviction' stocks of companies with strong pricing power and at least 20% upside potential to UBS targets<blockquote>以下是10只“高度确信”的公司股票，它们具有强大的定价能力，比瑞银目标至少有20%的上涨潜力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2173948607","media":"MarketWatch","summary":"UBS expects pricing power to be even more important as shipping, raw materials and wage costs surge. Inflation and supply issues are among the buzziest words on Wall Street as the third-quarter earnings reporting season approaches, with investors waiting to see which companies were the best at managing surging cost pressures and shipping disruptions.UBS strategists believe one of the best ways to deal with these headwinds is for a company to raise prices, but not all companies can do so by enoug","content":"<p>UBS expects pricing power to be even more important as shipping, raw materials and wage costs surge</p><p><blockquote>瑞银预计，随着航运、原材料和工资成本飙升，定价权将变得更加重要</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c9666acc8b6cbedd5fb585565a168bcf\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>盖蒂图片</span></p></blockquote></p><p> Inflation and supply issues are among the buzziest words on Wall Street as the third-quarter earnings reporting season approaches, with investors waiting to see which companies were the best at managing surging cost pressures and shipping disruptions.</p><p><blockquote>随着第三季度财报季的临近，通胀和供应问题是华尔街最热门的词汇之一，投资者等着看哪些公司最擅长管理飙升的成本压力和航运中断。</blockquote></p><p> UBS strategists believe one of the best ways to deal with these headwinds is for a company to raise prices, but not all companies can do so by enough to make a real difference without losing customers.</p><p><blockquote>瑞银策略师认为，应对这些不利因素的最佳方法之一是公司提高价格，但并非所有公司都能提高价格，从而在不失去客户的情况下产生真正的影响。</blockquote></p><p> A number of companies in different sectors have already cut forward guidance, given rising costs and supply-chain disruptions, such as FedEx Corp.,Nu Skin Enterprises Inc.&nbsp;and Dollar Tree Inc..</p><p><blockquote>鉴于成本上升和供应链中断，不同行业的许多公司已经下调了前瞻性指引，如联邦快递公司、如新企业公司和美元树公司..</blockquote></p><p> Third-quarter earnings season kicks off in earnest next week, with aggregate earnings per share of the S&amp;P 500 companies&nbsp;expected to show year-over-year growth in earnings per share of about 27% and in sales of about 15%.</p><p><blockquote>第三季度财报季将于下周正式拉开帷幕，标普500公司的每股收益总额预计将同比增长约27%，销售额将同比增长约15%。</blockquote></p><p> “Pricing power should be an even more important theme for relative returns with surging shipping costs, rising raw materials, supply chain issues and accelerating wage growth,” UBS strategists wrote in a note to clients this week.</p><p><blockquote>瑞银策略师本周在给客户的一份报告中写道：“随着运输成本飙升、原材料上涨、供应链问题和工资增长加速，定价能力应该成为相对回报的一个更加重要的主题。”</blockquote></p><p> So the strategists, led by Keith Parker, asked UBS analysts across 33 industries to identify companies with the strongest relative pricing power. The analysts were also asked to pick out companies that scored in the top third of their respective sectors based on UBS Equity Strategy’s composite score for pricing power, margin momentum and input cost exposure; have “buy” ratings; and have stocks with at least 10% upside potential to their respective price targets.</p><p><blockquote>因此，由基思·帕克（Keith Parker）领导的策略师要求瑞银（UBS）33个行业的分析师找出相对定价能力最强的公司。分析师还被要求根据瑞银股票策略在定价能力、利润率势头和投入成本敞口方面的综合得分，选出在各自行业中得分排名前三分之一的公司；拥有“买入”评级；并且股票的价格目标至少有10%的上涨潜力。</blockquote></p><p> Here are 10 “high conviction, strong pricing power stocks” on UBS’s list that have at least 20% upside to the analysts’ stock price targets, in alphabetical order:</p><p><blockquote>以下是瑞银名单上的10只“信念坚定、定价能力强的股票”，它们比分析师的股价目标至少有20%的上涨空间，按字母顺序排列：</blockquote></p><p> <ul>  <li>Advance Auto Parts Inc.,with a price target of $255, which implies an upside of about 21% to prices in afternoon trading Wednesday. Analyst Michael Lasser said he believes the auto parts company’s (AAP) aftermarket fundamentals are in a strong position, and that a gradual increase in mobility and a return to working in offices should drive further recovery in vehicle miles traveled.</li> </ul> “The auto parts sector traditionally has strong pricing power, with an ability to pass along price increases to customers,” Lasser wrote. “Plus, AAP also have the largest exposure to the commercial segment of the market, which is viewed even more favorably.”</p><p><blockquote><ul><li>Advance Auto Parts Inc.，目标价为255美元，这意味着周三下午交易的价格有约21%的上涨空间。分析师迈克尔·拉瑟(Michael Lasser)表示，他认为这家汽车零部件公司(AAP)的售后市场基本面处于强势地位，流动性的逐步增加和重返办公室工作应该会推动车辆行驶里程的进一步恢复。</li></ul>“汽车零部件行业传统上拥有强大的定价权，能够将价格上涨转嫁给客户，”拉塞尔写道。“此外，AAP在市场的商业领域也拥有最大的敞口，这一点受到了更多的青睐。”</blockquote></p><p> <ul>  <li>Apple Inc.,which has a price target of $175 that implies 24% upside. Analyst David Vogt said the combination of its technological capability, supported by its retention metrics from UBS surveys that indicate high customer satisfaction for Apple products, suggests the PC and smartphone giant’s brand equity should drive adoption in the battery-electric-vehicle (BEV) market.</li> </ul> “End-market demand has been improving year-over-year, leading to elevated ‘wait times’ despite increased product procurement/production,” Vogt wrote. Regarding the BEV market, Vogt said that while Apple isn’t a first mover, “its significant resources should enable the company to be a ‘fast follower,'” similar to when it entered the smartphone market in 2007.</p><p><blockquote><ul><li>苹果公司的目标价为175美元，意味着24%的上涨空间。分析师David Vogt表示，瑞银调查显示客户对苹果产品的满意度很高，其技术能力的结合表明，这家个人电脑和智能手机巨头的品牌资产应该会推动电池电动汽车(BEV)市场的采用。</li></ul>沃格特写道：“尽管产品采购/产量增加，但终端市场需求逐年改善，导致‘等待时间’增加。”关于纯电动汽车市场，Vogt表示，虽然苹果不是先行者，但“其大量资源应该使该公司成为‘快速追随者’”，类似于2007年进入智能手机市场时。</blockquote></p><p> <ul>  <li>CME Group Inc.,with a price target of $245 implying 23% upside. Analyst Alex Kramm said the derivatives trading platform benefits from global expansion, innovation, adoption of options and pricing. And he believes regulation could provide a tailwind to growth.</li> </ul> “As primarily a U.S. futures business, CME enjoys the highest barriers of entry in the space,” Kramm wrote.</p><p><blockquote><ul><li>CME Group Inc.，目标价为245美元，意味着上涨23%。分析师Alex Kramm表示，该衍生品交易平台受益于全球扩张、创新、期权的采用和定价。他认为监管可以为增长提供推动力。</li></ul>克拉姆写道：“作为一家主要的美国期货企业，芝商所在该领域享有最高的进入壁垒。”</blockquote></p><p> <ul>  <li>Danaher Corp.&nbsp;has a price target of $365, which implies 22% upside. Analyst John Sourbeer believes the medical products and services company (DHR) is “very well positioned” within the life sciences tool and services sector, as COVID testing should hold up much better than peers and the vaccine and therapeutic opportunity appears durable.</li> </ul> “DHR sales engine is able to proactively identify areas of potential pricing pressure and [successfully] navigate customers to high-value product,” Sourbeer wrote.</p><p><blockquote><ul><li>丹纳赫公司的目标价为365美元，这意味着22%的上涨空间。分析师John Sourbeer认为，医疗产品和服务公司(DHR)在生命科学工具和服务领域“处于非常有利的地位”，因为新冠病毒检测应该比同行好得多，而且疫苗和治疗机会似乎是持久的。</li></ul>Sourbeer写道：“DHR销售引擎能够主动识别潜在定价压力的领域，并[成功地]引导客户购买高价值产品。”</blockquote></p><p></p><p> <ul>  <li>EOG Resources Inc.&nbsp;has a $119 stock price target that suggests 38% upside. Analyst Lloyd Byrne the oil and natural gas exploration company is well positioned to mitigate inflationary pressures expected next year given well costs that are expected to be flat to lower in 2022 because of reduced drilling days, the deployment of “super zipper fracs” and contracts negotiated at lower rates.</li> </ul> “Pricing power in commodity companies is difficult to achieve. Those that can hold margins by best controlling costs, though, are better positioned,” Byrne wrote. “EOG is better positioned than most by being proactive with input and service costs, while excelling in operations.”</p><p><blockquote><ul><li>EOG Resources Inc.的目标股价为119美元，上涨38%。分析师劳埃德·伯恩(Lloyd Byrne)鉴于由于钻井天数减少、部署“超级拉链压裂”和合同谈判，预计2022年油井成本将持平或下降，这家石油和天然气勘探公司处于有利地位，可以缓解明年预计的通胀压力。较低的利率。</li></ul>“大宗商品公司的定价权很难实现。不过，那些能够通过最佳控制成本来保持利润的公司处于更有利的地位，”伯恩写道。“EOG比大多数公司处于更有利的地位，因为它积极主动地降低投入和服务成本，同时在运营方面表现出色。”</blockquote></p><p> <ul>  <li>Extra Space Storage Inc.’s&nbsp;stock price target of $210 implies 24% upside. Analyst Michael Goldsmith said he believes strong underlying demand, in conjunction with decelerating supply growth, support rent growth.</li> </ul> “Strong demand for self storage and elevated occupancy rates, combined with its non-discretionary nature increased pricing power of the operators,” Goldsmith wrote. “Operators are flexing their pricing power to new customers, as well as existing customer rent increases every 9-12 months.”</p><p><blockquote><ul><li>Extra Space Storage Inc.的目标股价为210美元，意味着上涨24%。分析师迈克尔·戈德史密斯表示，他认为强劲的潜在需求，加上供应增长放缓，将支撑租金增长。</li></ul>戈德史密斯写道：“对自助存储的强劲需求和较高的入住率，加上其非自由支配的性质，增加了运营商的定价能力。”“运营商正在向新客户展示他们的定价权，现有客户的租金每9-12个月上涨一次。”</blockquote></p><p> <ul>  <li>Generac Holdings Inc.&nbsp;has a price target of $500, which implies 23% upside. Analyst Jon Windham believes the power generation equipment maker’s competitive edge lies in its customer acquisition platform, which should enable it to take market share from incumbents SolarEdge Technologies Inc.&nbsp;and Enphase Energy Inc..</li> </ul> “Dominant market share (~80%) and strong demand for home standby power have insulated already high residential product margins,” Windham wrote.</p><p><blockquote><ul><li>Generac Holdings Inc.的目标价为500美元，这意味着上涨23%。分析师Jon Windham认为，这家发电设备制造商的竞争优势在于其客户获取平台，这将使其能够从现有企业SolarEdge Technologies Inc.和Enphase Energy Inc.手中夺取市场份额。</li></ul>温德姆写道：“主导市场份额（约80%）和对家庭备用电源的强劲需求使本已很高的住宅产品利润率受到影响。”</blockquote></p><p> <ul>  <li>Nike Inc.’s&nbsp;price target of $185 implies 24% upside. Analyst Jay Sole said a UBS survey and pricing data reveal that the Nike brand currently is No. 1 in mindshare globally and the sports apparel and accessories company has significant room to reduce promotions.</li> </ul> “We believe the market doesn’t fully appreciate how Nike’s investments in product innovation, supply chain and e-commerce are working in concert to drive unit growth and [average selling price] increases,” Sole wrote.</p><p><blockquote><ul><li>耐克公司185美元的目标价意味着24%的上涨空间。分析师Jay Sole表示，瑞银的调查和定价数据显示，耐克品牌目前在全球关注度排名第一，这家运动服装和配饰公司有很大的空间减少促销活动。</li></ul>Sole写道：“我们认为市场并没有完全理解耐克在产品创新、供应链和电子商务方面的投资如何协同推动销量增长和[平均售价]上涨。”</blockquote></p><p> <ul>  <li>Salesforce.com Inc.&nbsp;has a stock price target of $330 that implies 20% upside potential. Analyst Karl Keirstead said the customer relationship management software company appears to be moving well beyond the previous era of limited operating margin expansion, and committing to boosting annual operating margins.</li> </ul> “Importantly, the drivers behind the improved margin outlook strike us as sustainable, with topline outperformance, a permanent shift towards WFH [work from home] and Zoom-based customer interactions, and renewed expense discipline internally…the three biggest drivers,” Keirstead wrote.</p><p><blockquote><ul><li>Salesforce.com Inc.的目标股价为330美元，这意味着20%的上涨潜力。分析师Karl Keirstead表示，这家客户关系管理软件公司似乎正在远远超越之前营业利润率扩张有限的时代，并致力于提高年度营业利润率。</li></ul>“重要的是，利润率前景改善背后的驱动因素在我们看来是可持续的，营收表现出色，永久转向WFH（在家工作）和基于Zoom的客户互动，以及内部更新的费用纪律……这是三个最大的驱动因素，”凯尔斯泰德写道。</blockquote></p><p> <ul>  <li>Teleflex Inc.’s price target of $480 implies 28% upside. Analyst Matthew Taylor said the medical technology products company makes a number of inexpensive products that fly under the radar, given them the opportunity to increase prices.</li> </ul> Taylor said he believes margins can go “significantly higher” over the long term, given the company’s leverage to both necessary and elective procedures, which should return quickly in a post-pandemic world.</p><p><blockquote><ul><li>Teleflex Inc.的目标价为480美元，意味着上涨28%。分析师马修·泰勒表示，这家医疗技术产品公司生产了许多不为人所知的廉价产品，这给了他们提高价格的机会。</li></ul>泰勒表示，鉴于该公司在必要程序和选择性程序方面的影响力，他相信从长远来看，利润率可能会“显着提高”，而在大流行后的世界中，这些程序应该会迅速恢复。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here are 10 'high conviction' stocks of companies with strong pricing power and at least 20% upside potential to UBS targets<blockquote>以下是10只“高度确信”的公司股票，它们具有强大的定价能力，比瑞银目标至少有20%的上涨潜力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere are 10 'high conviction' stocks of companies with strong pricing power and at least 20% upside potential to UBS targets<blockquote>以下是10只“高度确信”的公司股票，它们具有强大的定价能力，比瑞银目标至少有20%的上涨潜力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-10-07 09:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p>UBS expects pricing power to be even more important as shipping, raw materials and wage costs surge</p><p><blockquote>瑞银预计，随着航运、原材料和工资成本飙升，定价权将变得更加重要</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c9666acc8b6cbedd5fb585565a168bcf\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>盖蒂图片</span></p></blockquote></p><p> Inflation and supply issues are among the buzziest words on Wall Street as the third-quarter earnings reporting season approaches, with investors waiting to see which companies were the best at managing surging cost pressures and shipping disruptions.</p><p><blockquote>随着第三季度财报季的临近，通胀和供应问题是华尔街最热门的词汇之一，投资者等着看哪些公司最擅长管理飙升的成本压力和航运中断。</blockquote></p><p> UBS strategists believe one of the best ways to deal with these headwinds is for a company to raise prices, but not all companies can do so by enough to make a real difference without losing customers.</p><p><blockquote>瑞银策略师认为，应对这些不利因素的最佳方法之一是公司提高价格，但并非所有公司都能提高价格，从而在不失去客户的情况下产生真正的影响。</blockquote></p><p> A number of companies in different sectors have already cut forward guidance, given rising costs and supply-chain disruptions, such as FedEx Corp.,Nu Skin Enterprises Inc.&nbsp;and Dollar Tree Inc..</p><p><blockquote>鉴于成本上升和供应链中断，不同行业的许多公司已经下调了前瞻性指引，如联邦快递公司、如新企业公司和美元树公司..</blockquote></p><p> Third-quarter earnings season kicks off in earnest next week, with aggregate earnings per share of the S&amp;P 500 companies&nbsp;expected to show year-over-year growth in earnings per share of about 27% and in sales of about 15%.</p><p><blockquote>第三季度财报季将于下周正式拉开帷幕，标普500公司的每股收益总额预计将同比增长约27%，销售额将同比增长约15%。</blockquote></p><p> “Pricing power should be an even more important theme for relative returns with surging shipping costs, rising raw materials, supply chain issues and accelerating wage growth,” UBS strategists wrote in a note to clients this week.</p><p><blockquote>瑞银策略师本周在给客户的一份报告中写道：“随着运输成本飙升、原材料上涨、供应链问题和工资增长加速，定价能力应该成为相对回报的一个更加重要的主题。”</blockquote></p><p> So the strategists, led by Keith Parker, asked UBS analysts across 33 industries to identify companies with the strongest relative pricing power. The analysts were also asked to pick out companies that scored in the top third of their respective sectors based on UBS Equity Strategy’s composite score for pricing power, margin momentum and input cost exposure; have “buy” ratings; and have stocks with at least 10% upside potential to their respective price targets.</p><p><blockquote>因此，由基思·帕克（Keith Parker）领导的策略师要求瑞银（UBS）33个行业的分析师找出相对定价能力最强的公司。分析师还被要求根据瑞银股票策略在定价能力、利润率势头和投入成本敞口方面的综合得分，选出在各自行业中得分排名前三分之一的公司；拥有“买入”评级；并且股票的价格目标至少有10%的上涨潜力。</blockquote></p><p> Here are 10 “high conviction, strong pricing power stocks” on UBS’s list that have at least 20% upside to the analysts’ stock price targets, in alphabetical order:</p><p><blockquote>以下是瑞银名单上的10只“信念坚定、定价能力强的股票”，它们比分析师的股价目标至少有20%的上涨空间，按字母顺序排列：</blockquote></p><p> <ul>  <li>Advance Auto Parts Inc.,with a price target of $255, which implies an upside of about 21% to prices in afternoon trading Wednesday. Analyst Michael Lasser said he believes the auto parts company’s (AAP) aftermarket fundamentals are in a strong position, and that a gradual increase in mobility and a return to working in offices should drive further recovery in vehicle miles traveled.</li> </ul> “The auto parts sector traditionally has strong pricing power, with an ability to pass along price increases to customers,” Lasser wrote. “Plus, AAP also have the largest exposure to the commercial segment of the market, which is viewed even more favorably.”</p><p><blockquote><ul><li>Advance Auto Parts Inc.，目标价为255美元，这意味着周三下午交易的价格有约21%的上涨空间。分析师迈克尔·拉瑟(Michael Lasser)表示，他认为这家汽车零部件公司(AAP)的售后市场基本面处于强势地位，流动性的逐步增加和重返办公室工作应该会推动车辆行驶里程的进一步恢复。</li></ul>“汽车零部件行业传统上拥有强大的定价权，能够将价格上涨转嫁给客户，”拉塞尔写道。“此外，AAP在市场的商业领域也拥有最大的敞口，这一点受到了更多的青睐。”</blockquote></p><p> <ul>  <li>Apple Inc.,which has a price target of $175 that implies 24% upside. Analyst David Vogt said the combination of its technological capability, supported by its retention metrics from UBS surveys that indicate high customer satisfaction for Apple products, suggests the PC and smartphone giant’s brand equity should drive adoption in the battery-electric-vehicle (BEV) market.</li> </ul> “End-market demand has been improving year-over-year, leading to elevated ‘wait times’ despite increased product procurement/production,” Vogt wrote. Regarding the BEV market, Vogt said that while Apple isn’t a first mover, “its significant resources should enable the company to be a ‘fast follower,'” similar to when it entered the smartphone market in 2007.</p><p><blockquote><ul><li>苹果公司的目标价为175美元，意味着24%的上涨空间。分析师David Vogt表示，瑞银调查显示客户对苹果产品的满意度很高，其技术能力的结合表明，这家个人电脑和智能手机巨头的品牌资产应该会推动电池电动汽车(BEV)市场的采用。</li></ul>沃格特写道：“尽管产品采购/产量增加，但终端市场需求逐年改善，导致‘等待时间’增加。”关于纯电动汽车市场，Vogt表示，虽然苹果不是先行者，但“其大量资源应该使该公司成为‘快速追随者’”，类似于2007年进入智能手机市场时。</blockquote></p><p> <ul>  <li>CME Group Inc.,with a price target of $245 implying 23% upside. Analyst Alex Kramm said the derivatives trading platform benefits from global expansion, innovation, adoption of options and pricing. And he believes regulation could provide a tailwind to growth.</li> </ul> “As primarily a U.S. futures business, CME enjoys the highest barriers of entry in the space,” Kramm wrote.</p><p><blockquote><ul><li>CME Group Inc.，目标价为245美元，意味着上涨23%。分析师Alex Kramm表示，该衍生品交易平台受益于全球扩张、创新、期权的采用和定价。他认为监管可以为增长提供推动力。</li></ul>克拉姆写道：“作为一家主要的美国期货企业，芝商所在该领域享有最高的进入壁垒。”</blockquote></p><p> <ul>  <li>Danaher Corp.&nbsp;has a price target of $365, which implies 22% upside. Analyst John Sourbeer believes the medical products and services company (DHR) is “very well positioned” within the life sciences tool and services sector, as COVID testing should hold up much better than peers and the vaccine and therapeutic opportunity appears durable.</li> </ul> “DHR sales engine is able to proactively identify areas of potential pricing pressure and [successfully] navigate customers to high-value product,” Sourbeer wrote.</p><p><blockquote><ul><li>丹纳赫公司的目标价为365美元，这意味着22%的上涨空间。分析师John Sourbeer认为，医疗产品和服务公司(DHR)在生命科学工具和服务领域“处于非常有利的地位”，因为新冠病毒检测应该比同行好得多，而且疫苗和治疗机会似乎是持久的。</li></ul>Sourbeer写道：“DHR销售引擎能够主动识别潜在定价压力的领域，并[成功地]引导客户购买高价值产品。”</blockquote></p><p></p><p> <ul>  <li>EOG Resources Inc.&nbsp;has a $119 stock price target that suggests 38% upside. Analyst Lloyd Byrne the oil and natural gas exploration company is well positioned to mitigate inflationary pressures expected next year given well costs that are expected to be flat to lower in 2022 because of reduced drilling days, the deployment of “super zipper fracs” and contracts negotiated at lower rates.</li> </ul> “Pricing power in commodity companies is difficult to achieve. Those that can hold margins by best controlling costs, though, are better positioned,” Byrne wrote. “EOG is better positioned than most by being proactive with input and service costs, while excelling in operations.”</p><p><blockquote><ul><li>EOG Resources Inc.的目标股价为119美元，上涨38%。分析师劳埃德·伯恩(Lloyd Byrne)鉴于由于钻井天数减少、部署“超级拉链压裂”和合同谈判，预计2022年油井成本将持平或下降，这家石油和天然气勘探公司处于有利地位，可以缓解明年预计的通胀压力。较低的利率。</li></ul>“大宗商品公司的定价权很难实现。不过，那些能够通过最佳控制成本来保持利润的公司处于更有利的地位，”伯恩写道。“EOG比大多数公司处于更有利的地位，因为它积极主动地降低投入和服务成本，同时在运营方面表现出色。”</blockquote></p><p> <ul>  <li>Extra Space Storage Inc.’s&nbsp;stock price target of $210 implies 24% upside. Analyst Michael Goldsmith said he believes strong underlying demand, in conjunction with decelerating supply growth, support rent growth.</li> </ul> “Strong demand for self storage and elevated occupancy rates, combined with its non-discretionary nature increased pricing power of the operators,” Goldsmith wrote. “Operators are flexing their pricing power to new customers, as well as existing customer rent increases every 9-12 months.”</p><p><blockquote><ul><li>Extra Space Storage Inc.的目标股价为210美元，意味着上涨24%。分析师迈克尔·戈德史密斯表示，他认为强劲的潜在需求，加上供应增长放缓，将支撑租金增长。</li></ul>戈德史密斯写道：“对自助存储的强劲需求和较高的入住率，加上其非自由支配的性质，增加了运营商的定价能力。”“运营商正在向新客户展示他们的定价权，现有客户的租金每9-12个月上涨一次。”</blockquote></p><p> <ul>  <li>Generac Holdings Inc.&nbsp;has a price target of $500, which implies 23% upside. Analyst Jon Windham believes the power generation equipment maker’s competitive edge lies in its customer acquisition platform, which should enable it to take market share from incumbents SolarEdge Technologies Inc.&nbsp;and Enphase Energy Inc..</li> </ul> “Dominant market share (~80%) and strong demand for home standby power have insulated already high residential product margins,” Windham wrote.</p><p><blockquote><ul><li>Generac Holdings Inc.的目标价为500美元，这意味着上涨23%。分析师Jon Windham认为，这家发电设备制造商的竞争优势在于其客户获取平台，这将使其能够从现有企业SolarEdge Technologies Inc.和Enphase Energy Inc.手中夺取市场份额。</li></ul>温德姆写道：“主导市场份额（约80%）和对家庭备用电源的强劲需求使本已很高的住宅产品利润率受到影响。”</blockquote></p><p> <ul>  <li>Nike Inc.’s&nbsp;price target of $185 implies 24% upside. Analyst Jay Sole said a UBS survey and pricing data reveal that the Nike brand currently is No. 1 in mindshare globally and the sports apparel and accessories company has significant room to reduce promotions.</li> </ul> “We believe the market doesn’t fully appreciate how Nike’s investments in product innovation, supply chain and e-commerce are working in concert to drive unit growth and [average selling price] increases,” Sole wrote.</p><p><blockquote><ul><li>耐克公司185美元的目标价意味着24%的上涨空间。分析师Jay Sole表示，瑞银的调查和定价数据显示，耐克品牌目前在全球关注度排名第一，这家运动服装和配饰公司有很大的空间减少促销活动。</li></ul>Sole写道：“我们认为市场并没有完全理解耐克在产品创新、供应链和电子商务方面的投资如何协同推动销量增长和[平均售价]上涨。”</blockquote></p><p> <ul>  <li>Salesforce.com Inc.&nbsp;has a stock price target of $330 that implies 20% upside potential. Analyst Karl Keirstead said the customer relationship management software company appears to be moving well beyond the previous era of limited operating margin expansion, and committing to boosting annual operating margins.</li> </ul> “Importantly, the drivers behind the improved margin outlook strike us as sustainable, with topline outperformance, a permanent shift towards WFH [work from home] and Zoom-based customer interactions, and renewed expense discipline internally…the three biggest drivers,” Keirstead wrote.</p><p><blockquote><ul><li>Salesforce.com Inc.的目标股价为330美元，这意味着20%的上涨潜力。分析师Karl Keirstead表示，这家客户关系管理软件公司似乎正在远远超越之前营业利润率扩张有限的时代，并致力于提高年度营业利润率。</li></ul>“重要的是，利润率前景改善背后的驱动因素在我们看来是可持续的，营收表现出色，永久转向WFH（在家工作）和基于Zoom的客户互动，以及内部更新的费用纪律……这是三个最大的驱动因素，”凯尔斯泰德写道。</blockquote></p><p> <ul>  <li>Teleflex Inc.’s price target of $480 implies 28% upside. Analyst Matthew Taylor said the medical technology products company makes a number of inexpensive products that fly under the radar, given them the opportunity to increase prices.</li> </ul> Taylor said he believes margins can go “significantly higher” over the long term, given the company’s leverage to both necessary and elective procedures, which should return quickly in a post-pandemic world.</p><p><blockquote><ul><li>Teleflex Inc.的目标价为480美元，意味着上涨28%。分析师马修·泰勒表示，这家医疗技术产品公司生产了许多不为人所知的廉价产品，这给了他们提高价格的机会。</li></ul>泰勒表示，鉴于该公司在必要程序和选择性程序方面的影响力，他相信从长远来看，利润率可能会“显着提高”，而在大流行后的世界中，这些程序应该会迅速恢复。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/here-are-10-high-conviction-stocks-of-companies-with-strong-pricing-power-and-at-least-20-upside-potential-to-ubs-targets-11633547178?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CME":"芝加哥商品交易所","NUS":"如新集团","AAP":"Advance Auto Parts Inc","SBAC":"SBA通信","EOG":"依欧格资源","ENPH":"Enphase Energy","AAPL":"苹果","AEE":"阿曼瑞恩","DLTR":"美元树公司","CRM":"赛富时","USB":"美国合众银行","KO":"可口可乐","EXR":"Extra Space Storage Inc","FDX":"联邦快递","SEDG":"SolarEdge Technologies, Inc.","DHR":"丹纳赫","CHTR":"特许通讯","GNRC":"Generac控股","NKE":"耐克"},"source_url":"https://www.marketwatch.com/story/here-are-10-high-conviction-stocks-of-companies-with-strong-pricing-power-and-at-least-20-upside-potential-to-ubs-targets-11633547178?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173948607","content_text":"UBS expects pricing power to be even more important as shipping, raw materials and wage costs surge\nGetty Images\nInflation and supply issues are among the buzziest words on Wall Street as the third-quarter earnings reporting season approaches, with investors waiting to see which companies were the best at managing surging cost pressures and shipping disruptions.\nUBS strategists believe one of the best ways to deal with these headwinds is for a company to raise prices, but not all companies can do so by enough to make a real difference without losing customers.\nA number of companies in different sectors have already cut forward guidance, given rising costs and supply-chain disruptions, such as FedEx Corp.,Nu Skin Enterprises Inc. and Dollar Tree Inc..\nThird-quarter earnings season kicks off in earnest next week, with aggregate earnings per share of the S&P 500 companies expected to show year-over-year growth in earnings per share of about 27% and in sales of about 15%.\n“Pricing power should be an even more important theme for relative returns with surging shipping costs, rising raw materials, supply chain issues and accelerating wage growth,” UBS strategists wrote in a note to clients this week.\nSo the strategists, led by Keith Parker, asked UBS analysts across 33 industries to identify companies with the strongest relative pricing power. The analysts were also asked to pick out companies that scored in the top third of their respective sectors based on UBS Equity Strategy’s composite score for pricing power, margin momentum and input cost exposure; have “buy” ratings; and have stocks with at least 10% upside potential to their respective price targets.\nHere are 10 “high conviction, strong pricing power stocks” on UBS’s list that have at least 20% upside to the analysts’ stock price targets, in alphabetical order:\n\nAdvance Auto Parts Inc.,with a price target of $255, which implies an upside of about 21% to prices in afternoon trading Wednesday. Analyst Michael Lasser said he believes the auto parts company’s (AAP) aftermarket fundamentals are in a strong position, and that a gradual increase in mobility and a return to working in offices should drive further recovery in vehicle miles traveled.\n\n“The auto parts sector traditionally has strong pricing power, with an ability to pass along price increases to customers,” Lasser wrote. “Plus, AAP also have the largest exposure to the commercial segment of the market, which is viewed even more favorably.”\n\nApple Inc.,which has a price target of $175 that implies 24% upside. Analyst David Vogt said the combination of its technological capability, supported by its retention metrics from UBS surveys that indicate high customer satisfaction for Apple products, suggests the PC and smartphone giant’s brand equity should drive adoption in the battery-electric-vehicle (BEV) market.\n\n“End-market demand has been improving year-over-year, leading to elevated ‘wait times’ despite increased product procurement/production,” Vogt wrote. Regarding the BEV market, Vogt said that while Apple isn’t a first mover, “its significant resources should enable the company to be a ‘fast follower,'” similar to when it entered the smartphone market in 2007.\n\nCME Group Inc.,with a price target of $245 implying 23% upside. Analyst Alex Kramm said the derivatives trading platform benefits from global expansion, innovation, adoption of options and pricing. And he believes regulation could provide a tailwind to growth.\n\n“As primarily a U.S. futures business, CME enjoys the highest barriers of entry in the space,” Kramm wrote.\n\nDanaher Corp. has a price target of $365, which implies 22% upside. Analyst John Sourbeer believes the medical products and services company (DHR) is “very well positioned” within the life sciences tool and services sector, as COVID testing should hold up much better than peers and the vaccine and therapeutic opportunity appears durable.\n\n“DHR sales engine is able to proactively identify areas of potential pricing pressure and [successfully] navigate customers to high-value product,” Sourbeer wrote.\n\nEOG Resources Inc. has a $119 stock price target that suggests 38% upside. Analyst Lloyd Byrne the oil and natural gas exploration company is well positioned to mitigate inflationary pressures expected next year given well costs that are expected to be flat to lower in 2022 because of reduced drilling days, the deployment of “super zipper fracs” and contracts negotiated at lower rates.\n\n“Pricing power in commodity companies is difficult to achieve. Those that can hold margins by best controlling costs, though, are better positioned,” Byrne wrote. “EOG is better positioned than most by being proactive with input and service costs, while excelling in operations.”\n\nExtra Space Storage Inc.’s stock price target of $210 implies 24% upside. Analyst Michael Goldsmith said he believes strong underlying demand, in conjunction with decelerating supply growth, support rent growth.\n\n“Strong demand for self storage and elevated occupancy rates, combined with its non-discretionary nature increased pricing power of the operators,” Goldsmith wrote. “Operators are flexing their pricing power to new customers, as well as existing customer rent increases every 9-12 months.”\n\nGenerac Holdings Inc. has a price target of $500, which implies 23% upside. Analyst Jon Windham believes the power generation equipment maker’s competitive edge lies in its customer acquisition platform, which should enable it to take market share from incumbents SolarEdge Technologies Inc. and Enphase Energy Inc..\n\n“Dominant market share (~80%) and strong demand for home standby power have insulated already high residential product margins,” Windham wrote.\n\nNike Inc.’s price target of $185 implies 24% upside. Analyst Jay Sole said a UBS survey and pricing data reveal that the Nike brand currently is No. 1 in mindshare globally and the sports apparel and accessories company has significant room to reduce promotions.\n\n“We believe the market doesn’t fully appreciate how Nike’s investments in product innovation, supply chain and e-commerce are working in concert to drive unit growth and [average selling price] increases,” Sole wrote.\n\nSalesforce.com Inc. has a stock price target of $330 that implies 20% upside potential. Analyst Karl Keirstead said the customer relationship management software company appears to be moving well beyond the previous era of limited operating margin expansion, and committing to boosting annual operating margins.\n\n“Importantly, the drivers behind the improved margin outlook strike us as sustainable, with topline outperformance, a permanent shift towards WFH [work from home] and Zoom-based customer interactions, and renewed expense discipline internally…the three biggest drivers,” Keirstead wrote.\n\nTeleflex Inc.’s price target of $480 implies 28% upside. Analyst Matthew Taylor said the medical technology products company makes a number of inexpensive products that fly under the radar, given them the opportunity to increase prices.\n\nTaylor said he believes margins can go “significantly higher” over the long term, given the company’s leverage to both necessary and elective procedures, which should return quickly in a post-pandemic world.","news_type":1,"symbols_score_info":{"AAPL":0.9,"AEE":0.9,"CHTR":0.9,"EOG":0.9,"EXR":0.9,"KO":0.9,"CME":0.9,"AAP":0.9,"DLTR":0.9,"USB":0.9,"SEDG":0.9,"NKE":0.9,"FDX":0.9,"NUS":0.9,"CRM":0.9,"GNRC":0.9,"ENPH":0.9,"SBAC":0.9,"DHR":0.9}},"isVote":1,"tweetType":1,"viewCount":550,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":883291795,"gmtCreate":1631241532917,"gmtModify":1631889680825,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883291795","repostId":"2166426123","repostType":4,"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":879741253,"gmtCreate":1636779547878,"gmtModify":1636779547957,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879741253","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857301406,"gmtCreate":1635505743047,"gmtModify":1635505743273,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/857301406","repostId":"2179217592","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855348290,"gmtCreate":1635340270573,"gmtModify":1635340310687,"author":{"id":"4087701475296490","authorId":"4087701475296490","name":"Mb76","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087701475296490","authorIdStr":"4087701475296490"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855348290","repostId":"1163460191","repostType":4,"repost":{"id":"1163460191","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635336440,"share":"https://www.laohu8.com/m/news/1163460191?lang=zh_CN&edition=full","pubTime":"2021-10-27 20:07","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1163460191","media":"Tiger Newspress","summary":"US stock index futures were flat during early morning trading on Wednesday after the Dow and S&P clo","content":"<p>US&nbsp;stock index futures&nbsp;were flat&nbsp;during early morning trading on Wednesday after the Dow and S&amp;P closed at record highs as earnings season continues.<img src=\"https://static.tigerbbs.com/3ba3bdf4766121a57af16614b7de5ab1\" tg-width=\"1080\" tg-height=\"543\" referrerpolicy=\"no-referrer\">At 8:05 a.m. ET, Dow e-minis were up&nbsp;18&nbsp;points, or 0.05%, S&amp;P 500 e-minis were down&nbsp;2.5&nbsp;points, or 0.05%, and Nasdaq 100 e-minis were&nbsp;down&nbsp;17.25&nbsp;points, or 0.11%.</p><p><blockquote>随着财报季的继续，道琼斯指数和标准普尔指数收于历史新高，美国股指期货周三早盘持平。截至美国东部时间上午8:05，道指e-minis上涨18点，即0.05%，标普500 e-minis下跌2.5点，即0.05%，纳斯达克100 e-minis下跌17.25点，即0.11%。</blockquote></p><p> A busy earnings week continues on Wednesday with Coca-Cola, McDonald’s, Bristol-Myers, Boeing, General Motors and Harley-Davidson among the names on deck before the market opens. Ford, eBay and Yum China will provide quarterly updates after the market closes.</p><p><blockquote>周三，繁忙的财报周仍在继续，可口可乐、麦当劳、百时美施贵宝、波音、通用汽车和哈雷戴维森等公司都在开盘前上市。福特、eBay和百胜中国将在收盘后提供季度更新。</blockquote></p><p> On the economic front, U.S. durable goods order data will be released at 8:30 a.m. ET.</p><p><blockquote>经济方面，美国耐用品订单数据将于美东时间上午8:30公布。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <ul>  <li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> and&nbsp;<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>&nbsp;were among the headline reports Tuesday after the market closed, with both topping revenue expectations. Microsoft shares rose 2.3% in premarket trading.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/TXN\">Texas Instruments</a>&nbsp;shares tumbled 4% premarket after the companysaid it earned $1.95 billion, or $2.07 a share, in the quarter, compared with $1.3 billion, or $1.45 a share, in the year-ago period,and its revenue rose 22% to $4.64 billion.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;fell 2.5%in premarket trading although it reported increases in net revenue and earnings for its fiscal fourth quarter driven by higher payments volume, cross-border volume and processed transactions as economies opened up with the wider availability of Covid-19 vaccines.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a>&nbsp;leaped 12.7% after&nbsp;reporting record revenue&nbsp;in face of supply chain headwinds.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> rose 2.6% premarket after the company posted&nbsp;a beat on the top and bottom lines&nbsp;and raised its outlook, saying the business was getting stronger particularly in areas where the Covid recovery has been the best.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/HOOD\">Robinhood Markets, Inc.</a> shares were getting slammed, down 11% the day after the trading app&nbsp;reported revenue well below expectations&nbsp;primarily due to weakness in crypto trading.</li> </ul></p><p><blockquote><ul><li><a href=\"https://laohu8.com/S/MSFT\">微软</a>和<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>周二收盘后成为头条新闻，两者的收入都超出了预期。微软股价在盘前交易中上涨2.3%。</li></ul><ul><li><a href=\"https://laohu8.com/S/TXN\">德州仪器</a>该公司表示，本季度盈利19.5亿美元，即每股2.07美元，而去年同期为13亿美元，即每股1.45美元，该公司股价盘前下跌4%，营收增长22%，至46.4亿美元。</li></ul><ul><li><a href=\"https://laohu8.com/S/V\">签证</a>尽管该公司报告称，随着Covid-19疫苗的广泛普及，经济开放，支付量、跨境量和处理交易量增加，推动了第四财季净收入和收益的增长，但盘前交易中该公司仍下跌2.5%。</li></ul><ul><li><a href=\"https://laohu8.com/S/ENPH\">Enphase能源</a>面对供应链逆风，营收创历史新高，股价跃升12.7%。</li></ul><ul><li><a href=\"https://laohu8.com/S/KO\">可口可乐</a>盘前上涨2.6%，此前该公司公布了营收和利润，并上调了前景，称业务正在变得更加强劲，特别是在新冠疫情复苏最好的地区。</li></ul><ul><li><a href=\"https://laohu8.com/S/HOOD\">罗宾汉市场公司。</a>该交易应用程序报告收入远低于预期，主要是由于加密货币交易疲软，第二天股价暴跌11%。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-27 20:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>US&nbsp;stock index futures&nbsp;were flat&nbsp;during early morning trading on Wednesday after the Dow and S&amp;P closed at record highs as earnings season continues.<img src=\"https://static.tigerbbs.com/3ba3bdf4766121a57af16614b7de5ab1\" tg-width=\"1080\" tg-height=\"543\" referrerpolicy=\"no-referrer\">At 8:05 a.m. ET, Dow e-minis were up&nbsp;18&nbsp;points, or 0.05%, S&amp;P 500 e-minis were down&nbsp;2.5&nbsp;points, or 0.05%, and Nasdaq 100 e-minis were&nbsp;down&nbsp;17.25&nbsp;points, or 0.11%.</p><p><blockquote>随着财报季的继续，道琼斯指数和标准普尔指数收于历史新高，美国股指期货周三早盘持平。截至美国东部时间上午8:05，道指e-minis上涨18点，即0.05%，标普500 e-minis下跌2.5点，即0.05%，纳斯达克100 e-minis下跌17.25点，即0.11%。</blockquote></p><p> A busy earnings week continues on Wednesday with Coca-Cola, McDonald’s, Bristol-Myers, Boeing, General Motors and Harley-Davidson among the names on deck before the market opens. Ford, eBay and Yum China will provide quarterly updates after the market closes.</p><p><blockquote>周三，繁忙的财报周仍在继续，可口可乐、麦当劳、百时美施贵宝、波音、通用汽车和哈雷戴维森等公司都在开盘前上市。福特、eBay和百胜中国将在收盘后提供季度更新。</blockquote></p><p> On the economic front, U.S. durable goods order data will be released at 8:30 a.m. ET.</p><p><blockquote>经济方面，美国耐用品订单数据将于美东时间上午8:30公布。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <ul>  <li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> and&nbsp;<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>&nbsp;were among the headline reports Tuesday after the market closed, with both topping revenue expectations. Microsoft shares rose 2.3% in premarket trading.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/TXN\">Texas Instruments</a>&nbsp;shares tumbled 4% premarket after the companysaid it earned $1.95 billion, or $2.07 a share, in the quarter, compared with $1.3 billion, or $1.45 a share, in the year-ago period,and its revenue rose 22% to $4.64 billion.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;fell 2.5%in premarket trading although it reported increases in net revenue and earnings for its fiscal fourth quarter driven by higher payments volume, cross-border volume and processed transactions as economies opened up with the wider availability of Covid-19 vaccines.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a>&nbsp;leaped 12.7% after&nbsp;reporting record revenue&nbsp;in face of supply chain headwinds.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> rose 2.6% premarket after the company posted&nbsp;a beat on the top and bottom lines&nbsp;and raised its outlook, saying the business was getting stronger particularly in areas where the Covid recovery has been the best.</li> </ul> <ul>  <li><a href=\"https://laohu8.com/S/HOOD\">Robinhood Markets, Inc.</a> shares were getting slammed, down 11% the day after the trading app&nbsp;reported revenue well below expectations&nbsp;primarily due to weakness in crypto trading.</li> </ul></p><p><blockquote><ul><li><a href=\"https://laohu8.com/S/MSFT\">微软</a>和<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>周二收盘后成为头条新闻，两者的收入都超出了预期。微软股价在盘前交易中上涨2.3%。</li></ul><ul><li><a href=\"https://laohu8.com/S/TXN\">德州仪器</a>该公司表示，本季度盈利19.5亿美元，即每股2.07美元，而去年同期为13亿美元，即每股1.45美元，该公司股价盘前下跌4%，营收增长22%，至46.4亿美元。</li></ul><ul><li><a href=\"https://laohu8.com/S/V\">签证</a>尽管该公司报告称，随着Covid-19疫苗的广泛普及，经济开放，支付量、跨境量和处理交易量增加，推动了第四财季净收入和收益的增长，但盘前交易中该公司仍下跌2.5%。</li></ul><ul><li><a href=\"https://laohu8.com/S/ENPH\">Enphase能源</a>面对供应链逆风，营收创历史新高，股价跃升12.7%。</li></ul><ul><li><a href=\"https://laohu8.com/S/KO\">可口可乐</a>盘前上涨2.6%，此前该公司公布了营收和利润，并上调了前景，称业务正在变得更加强劲，特别是在新冠疫情复苏最好的地区。</li></ul><ul><li><a href=\"https://laohu8.com/S/HOOD\">罗宾汉市场公司。</a>该交易应用程序报告收入远低于预期，主要是由于加密货币交易疲软，第二天股价暴跌11%。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOOD":"Robinhood","ENPH":"Enphase Energy","GOOG":"谷歌","MSFT":"微软","KO":"可口可乐","V":"Visa","TXN":"德州仪器"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163460191","content_text":"US stock index futures were flat during early morning trading on Wednesday after the Dow and S&P closed at record highs as earnings season continues.At 8:05 a.m. ET, Dow e-minis were up 18 points, or 0.05%, S&P 500 e-minis were down 2.5 points, or 0.05%, and Nasdaq 100 e-minis were down 17.25 points, or 0.11%.\nA busy earnings week continues on Wednesday with Coca-Cola, McDonald’s, Bristol-Myers, Boeing, General Motors and Harley-Davidson among the names on deck before the market opens. Ford, eBay and Yum China will provide quarterly updates after the market closes.\nOn the economic front, U.S. durable goods order data will be released at 8:30 a.m. ET.\nStocks making the biggest moves in the premarket:\n\nMicrosoft and Alphabet were among the headline reports Tuesday after the market closed, with both topping revenue expectations. Microsoft shares rose 2.3% in premarket trading.\n\n\nTexas Instruments shares tumbled 4% premarket after the companysaid it earned $1.95 billion, or $2.07 a share, in the quarter, compared with $1.3 billion, or $1.45 a share, in the year-ago period,and its revenue rose 22% to $4.64 billion.\n\n\nVisa fell 2.5%in premarket trading although it reported increases in net revenue and earnings for its fiscal fourth quarter driven by higher payments volume, cross-border volume and processed transactions as economies opened up with the wider availability of Covid-19 vaccines.\n\n\nEnphase Energy leaped 12.7% after reporting record revenue in face of supply chain headwinds.\n\n\nCoca-Cola rose 2.6% premarket after the company posted a beat on the top and bottom lines and raised its outlook, saying the business was getting stronger particularly in areas where the Covid recovery has been the best.\n\n\nRobinhood Markets, Inc. shares were getting slammed, down 11% the day after the trading app reported revenue well below expectations primarily due to weakness in crypto trading.","news_type":1,"symbols_score_info":{"ENPH":0.9,"MSFT":0.9,"HOOD":0.9,"GOOG":0.9,"KO":0.9,"V":0.9,"TXN":0.9}},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}